Section 48

EurekaMag Full Text Articles Chapter 47,860


Dahlen, E.P.; Rittmann, B.E. 2002: Two-tank suspended growth process for accelerating the detoxification kinetics of hydrocarbons requiring initial monooxygenation reactions. Biodegradation 13(2): 101-116
Cauble; Rozmus 1995: Two-temperature frequency-dependent electrical resistivity in solid density plasmas produced by ultrashort laser pulses. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 52(3): 2974-2981
Rácz; Zia 1994: Two-temperature kinetic Ising model in one dimension: Steady-state correlations in terms of energy and energy flux. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 49(1): 139-144
Tamayo; Alexander; Gupta 1994: Two-temperature nonequilibrium Ising models: Critical behavior and universality. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 50(5): 3474-3484
Rikken; van Haaren JA; van der Wel W; van Gelder AP; van Kempen H; Wyder; André; Ploog; Weimann 1988: Two-terminal resistance of quantum Hall devices. Physical Review. B Condensed Matter 37(11): 6181-6186
Jensen, J.; Jackson, B.; Miklovic, N. 1985: Two-thirds of hospitals relying on marketing research studies. Modern Healthcare 15(20): 84-85
Hilmer, D.M. 1994: Technical considerations of bariatric surgery in the superobese. Surgical Technologist 26(7): 8
Dorfsman, M.L.; Menegazzi, J.J.; Wadas, R.J.; Auble, T.E. 2000: Two-thumb vs. two-finger chest compression in an infant model of prolonged cardiopulmonary resuscitation. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine 7(10): 1077-1082
Day, M. 1996: Two-tier treatment: why pick on us?. Nursing Times 92(8): 18
Brewer, T.F.; Heymann, S.J. 1998: Two-tiered health care: the root of ethical problems in recent clinical trials. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 2(3): 123-126
Cavallo, A.; Cosenza, F.; De Cesare, L. 2001: Two-time Green's functions and the spectral density method in nonextensive classical statistical mechanics. Physical Review Letters 87(24): 240602
Yeung; Jasnow 1990: Two-time correlations, self-averaging, and an analytically solvable model of phase-ordering dynamics. Physical Review. B Condensed Matter 42(16): 10523-10535
Huang; Zhu; Zubairy; Scully 1996: Two-time intensity correlation in a driven three-level system. Physical Review. A Atomic Molecular and Optical Physics 53(3): 1834-1838
Zamick; Zheng 1992: Two-to-one relationships between the spectra of selected even-even and even-odd nuclei. Physical Review. C Nuclear Physics 46(2): 815-818
Matar, L.D.; Frazer, C. 2001: Two-tone pancreas on T1-weighted images: correlation with abnormalities on magnetic resonance pancreatography. Australasian Radiology 45(1): 58-61
Nath, S.K.; Chen, C.H.; Schork, N.J. 2001: Two-trait-locus linkage analyses of asthma susceptibility. Genetic Epidemiology 21(Suppl 1): S278-S283
Lomanto, D.; De Angelis, L.; Ceci, V.; Dalsasso, G.; So, J.; Frattaroli, F.M.; Muthiah, R.; Speranza, V. 2001: Two-trocar laparoscopic cholecystectomy: a reproducible technique. Surgical Laparoscopy Endoscopy and Percutaneous Techniques 11(4): 248-251
Barrientos-Fortes, T.; Urbina-De la Vega, F. 1998: Two-trocar technique for terminal sigmoid colostomy in a patient with complex pelvic fracture. Surgical Endoscopy 12(6): 884-886
Botelho, M.G.; Nor, L.C.; Kwong, H.W.; Kuen, B.S. 2000: Two-unit cantilevered resin-bonded fixed partial dentures--a retrospective, preliminary clinical investigation. International Journal of Prosthodontics 13(1): 25-28
Fleishman, R.; Walk, D.; Mizrahi, G.; Bar-Giora, M. 1996: Two-unit reliability analysis of questionnaires used in a regulatory system. Evaluation Review 20(5): 580-595
Stetson, W.B.; Templin, K. 2002: Two-versus three-portal technique for routine knee arthroscopy. American Journal of Sports Medicine 30(1): 108-111
Lavezo, L.A.; Davis, R.L. 1994: Two-versus three-sample method for estimating gentamicin pharmacokinetic values. American Journal of Hospital Pharmacy 51(8): 1021-1024
Janssen; van der Avoird A 1992: Two-vibron excitations in the ferroelectric phase of NaNO2. Physical Review. B Condensed Matter 46(2): 831-837
Siegel 1993: Two-vierbein formalism for string-inspired axionic gravity. Physical Review. D Particles and Fields 47(12): 5453-5459
Law, J.; Faulkner, K. 2002: Two-view screening and extending the age range: the balance of benefit and risk. British Journal of Radiology 75(899): 889-894
Delmas, F.; Beloeil, J.C.; van der Sanden, B.P.; Nicolay, K.; Gillet, B. 2001: Two-voxel localization sequence for in vivo two-dimensional homonuclear correlation spectroscopy. Journal of Magnetic Resonance 149(1): 119-125
Smith, J.; Maas, I.; Mayer, K.Ulrich.; Helmchen, H.; Steinhagen-Thiessen, E.; Baltes, P.B. 2002: Two-wave longitudinal findings from the Berlin aging study: introduction to a collection of articles. Journals of Gerontology. Series B Psychological Sciences and Social Sciences 57(6): P471-P473
Kamenov; Hu; Shamonina; Ringhofer; Gayvoronsky 2000: Two-wave mixing in (111)-cut Bi12SiO20 and Bi12TiO20 crystals: characterization and comparison with the general orientation. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 62(2 Part B): 2863-2870
Suzuki, T.; Yazawa, T.; Sasaki, O. 2002: Two-wavelength laser diode interferometer with time-sharing sinusoidal phase modulation. Applied Optics 41(10): 1972-1976
Sala, R.; Rotoli, B.M.; Colla, E.; Visigalli, R.; Parolari, A.; Bussolati, O.; Gazzola, G.C.; Dall'Asta, V. 2002: Two-way arginine transport in human endothelial cells: TNF-alpha stimulation is restricted to system y(+). American Journal of Physiology. Cell Physiology 282(1): C134-C143
Lunsjö, K.; Ceder, L.; Stigsson, L.; Hauggaard, A. 1996: Two-way compression along the shaft and the neck of the femur with the Medoff sliding plate: one-year follow-up of 108 intertrochanteric fractures. Journal of Bone and Joint Surgery. British Volume 78(3): 387-390
Guan, S.; Marshall, A.G. 1997: Two-way conversation with a mass spectrometer: nondestructive interactive mass spectrometry. Analytical Chemistry 69(1): 1-4
Havice, P.A.; Knowles, M.H. 1995: Two-way interactive video: maximizing distance learning. Journal of Continuing Education in Nursing 26(1): 28-30
Spann, S.J. 1998: Two-way interactive videoconferencing: why bother?. Family Medicine 30(7): 513-514
Fryer, M.; Burns, S.; Hudson, H. 1985: Two-way radio for rural health care delivery. Development Communication Report 51: 5; 16
Shannon, C.; Gilmore, E. 1993: Two-way split. Nursing Times 89(5): 38-39
Martínez-López, J.I. 1993: Two-way street. Ventricular ectopic activity. Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 145(1): 5; 7-9
Oermann, M.H. 1999: Two-way talks. Nursing Management 30(6): 56-58
McFarlane, R.E.; Nissen, R.J. 1983: Two-way teleconferencing: room design comes first. Architectural Record 171(11): 112-119
Pauluhn, J.; Emura, M.; Mohr, U.; Popp, A.; Rosenbruch, M. 1999: Two-week inhalation toxicity of polymeric diphenylmethane-4, 4'-diisocyanate (PMDI) in rats: analysis of biochemical and morphological markers of early pulmonary response. Inhalation Toxicology 11(12): 1143-1163
O'Hehir, T.E. 1995: Two-week recall is helpful to specific patients' needs. Rdh 15(2): 15
Morgan, C.; Robertshaw, H.; Cooper, H.; Keohane, S. 2002: Two-week skin cancer referrals. Clinical and Experimental Dermatology 27(2): 164
Cesarone, M.R.; Incandela, L.; Belcaro, G.; De Sanctis, M.T.; Ricci, A.; Griffin, M. 2001: Two-week topical treatment with Essaven gel in patients with diabetic microangiopathy--a placebo-controlled, randomized study. Angiology 52(Suppl 3): S43-S48
Elliott, R. 1978: Fertility drop precedes development in Thailand. Pp News 1(3): 11
Mydler, T.T.; Wasserman, G.S.; Watson, W.A.; Knapp, J.F. 1993: Two-week-old infant with isopropanol intoxication. Pediatric Emergency Care 9(3): 146-148
Hinds, E.A.; Vale, C.J.; Boshier, M.G. 2001: Two-wire waveguide and interferometer for cold atoms. Physical Review Letters 86(8): 1462-1465
Meerkin; Joyal; Lespérance; Bonan 2001: Two-year QCA follow-up after post-PTCA beta-radiation in de novo lesions. Cardiovascular Radiation Medicine 2(1): 52
Jegaden, O.; Bontemps, L.; de Gevigney, G.; Chatel, C.; Itti, R.; Mikaeloff, P. 1999: Two-year assessment by exercise thallium scintigraphy of myocardial revascularization using bilateral internal mammary and gastroepiploic arteries. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 16(2): 131-134
Gales, A.C.; Jones, R.N.; Pfaller, M.A.; Gordon, K.A.; Sader, H.S. 2000: Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals: results from the SENTRY antimicrobial surveillance program, 1997-98. SENTRY Study Group. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 4(2): 75-84
Göhring, T.N.; Schmidlin, P.R.; Lutz, F. 2002: Two-year clinical and SEM evaluation of glass-fiber-reinforced inlay fixed partial dentures. American Journal of Dentistry 15(1): 35-40
Browning, W.D.; Brackett, W.W.; Gilpatrick, R.O. 2000: Two-year clinical comparison of a microfilled and a hybrid resin-based composite in non-carious Class V lesions. Operative Dentistry 25(1): 46-50
Demirci, M.; Uçok, M. 2002: Two-year clinical evaluation of Dyract in small Class i cavities. American Journal of Dentistry 15(5): 312-316
Perry, R.D.; Kugel, G. 2000: Two-year clinical evaluation of a high-density posterior restorative material. Compendium of Continuing Education in Dentistry 21(12): 1067-72 1074 1076 Passim; Quiz 1080
Belcher, M.A.; Stewart, G.P. 1997: Two-year clinical evaluation of an amalgam adhesive. Journal of the American Dental Association 128(3): 309-314
Scheibenbogen-Fuchsbrunner, A.; Manhart, J.; Kremers, L.; Kunzelmann, K.H.; Hickel, R. 1999: Two-year clinical evaluation of direct and indirect composite restorations in posterior teeth. Journal of Prosthetic Dentistry 82(4): 391-397
Ermiş, R.B. 2002: Two-year clinical evaluation of four polyacid-modified resin composites and a resin-modified glass-ionomer cement in Class V lesions. Quintessence International 33(7): 542-548
Moore, D.S.; Gilpatrick, R.O.; Cloyd, J.S. 1994: Two-year clinical evaluation of preventive resin restorations. Journal of the Tennessee Dental Association 74(2): 27-30
Swift, E.J.; May, K.N.; Wilder, A.D.; Heymann, H.O.; Bayne, S.C. 1999: Two-year clinical evaluation of tooth whitening using an at-home bleaching system. Journal of Esthetic Dentistry 11(1): 36-42
Van Meerbeek, B.; Braem, M.; Lambrechts, P.; Vanherle, G. 1993: Two-year clinical evaluation of two dentine-adhesive systems in cervical lesions. Journal of Dentistry 21(4): 195-202
Brackett, W.W.; Browning, W.D.; Ross, J.A.; Brackett, M.G. 2001: Two-year clinical performance of a polyacid-modified resin composite and a resin-modified glass-ionomer restorative material. Operative Dentistry 26(1): 12-16
Brackett, W.W.; Gilpatrick, R.O.; Browning, W.D.; Gregory, P.N. 1999: Two-year clinical performance of a resin-modified glass-ionomer restorative material. Operative Dentistry 24(1): 9-13
Zanconato, G. 1988: Two-year clinical performance of the Levonorgestrel 20 T IUD. Ginecologia Clinica 9(3): 281-285
Poresky, R.H.; Daniels, A.M. 2001: Two-year comparison of income, education, and depression among parents participating in regular Head Start or supplementary Family Service Center Services. Psychological Reports 88(3 Pt 1): 787-796
Meiers, J.C.; Young, D. 2001: Two-year composite/dentin bond stability. American Journal of Dentistry 14(3): 141-144
Azar, R.G.; Holdbrook, M.J.; Lemp, M.; Edelhauser, H.F. 2001: Two-year corneal endothelial cell assessment following INTACS implantation. Journal of Refractive Surgery 17(5): 542-548
Williams, R.; Neuhaus, P.; Bismuth, H.; McMaster, P.; Pichlmayr, R.; Calne, R.; Otto, G.; Groth, C. 1996: Two-year data from the European multicentre tacrolimus (FK506) liver study. Transplant International: Official Journal of the European Society for Organ Transplantation 9(Suppl 1): S144-S150
Anstey, K.J.; Luszcz, M.A.; Sanchez, L. 2001: Two-year decline in vision but not hearing is associated with memory decline in very old adults in a population-based sample. Gerontology 47(5): 289-293
Hatch, R.C.; Regan, K.S.; Ishibashi, S.; Nakazawa, M.; Iwakura, K.; Sumi, N. 1997: Two-year dietary carcinogenicity study of (+/-)-4-diethylamino-1, 1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in rats. Journal of Toxicological Sciences 22(Suppl 1): 289-306
Sobolev, A.V.; Sakhnova, T.A.; Kozhemyakina, E.S.; Chazova, I.E. 1996: Two-year dynamics of vectorcardiography parameters in patients with primary pulmonary hypertension. Bratislavske Lekarske Listy 97(9): 531-535
de Sauvage Nolting, P.R.W.; Buirma, R.J.A.; Hutten, B.A.; Kastelein, J.J.P. 2002: Two-year efficacy and safety of simvastatin 80 mg in familial hypercholesterolemia (the Examination of Probands and Relatives in Statin Studies With Familial Hypercholesterolemia [ExPRESS FH]). American Journal of Cardiology 90(2): 181-184
Vilkinis, V.; Hörsted-Bindslev, P.; Baelum, V. 2000: Two-year evaluation of class Ii resin-modified glass ionomer cement/composite open sandwich and composite restorations. Clinical Oral Investigations 4(3): 133-139
Suma, H.; Isomura, T.; Horii, T.; Sato, T.; Kikuchi, N.; Iwahashi, K.; Hosokawa, J. 1998: Two-year experience of the Batista operation for non-ischemic cardiomyopathy. Journal of Cardiology 32(4): 269-276
Seman, E.I.; Cook, J.R.; O'Shea, R.T. 2003: Two-year experience with laparoscopic pelvic floor repair. Journal of the American Association of Gynecologic Laparoscopists 10(1): 38-45
Windecker, S.; Bubien, R.S.; Halperin, L.; Moore, A.; Kay, G.N. 1998: Two-year experience with rate-modulated pacing controlled by mixed venous oxygen saturation. Pacing and Clinical Electrophysiology: Pace 21(7): 1396-1404
Penchev, R. 1998: Two-year experience with the jet dissector "Parenchymotome 01" in clinical practice. Khirurgiia 53(6): 52-56
Park, H.; Park, M.; Park, T. 1998: Two-year experience with ureteral stones: extracorporeal shockwave lithotripsy v ureteroscopic manipulation. Journal of Endourology 12(6): 501-504
Rogalski, R.; Huebner, J.; Goulet, J.; Kaufer, H. 1993: Two-year follow up of bipolar hemiarthroplasty. Orthopedics 16(7): 759-765
Cwikel, J.; Abdelgani, A.; Goldsmith, J.R.; Quastel, M.; Yevelson, I.I. 1997: Two-year follow up study of stress-related disorders among immigrants to Israel from the Chernobyl area. Environmental Health Perspectives 105 Suppl. 6: 1545-1550
Park, J.M.; Mataix-Cols, D.; Marks, I.M.; Ngamthipwatthana, T.; Marks, M.; Araya, R.; Al-Kubaisy, T. 2001: Two-year follow-up after a randomised controlled trial of self- and clinician-accompanied exposure for phobia/panic disorders. British Journal of Psychiatry: the Journal of Mental Science 178: 543-548
Campbell, W.B.; Ridler, B.M.; Szymanska, T.H. 2000: Two-year follow-up after acute thromboembolic limb ischaemia: the importance of anticoagulation. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 19(2): 169-173
Condado, J.A.; Waksman, R.; Calderas, C.; Saucedo, J.; Lansky, A. 1999: Two-year follow-up after intracoronary gamma radiation therapy. Cardiovascular Radiation Medicine 1(1): 30-35
Nyamathi, A.M.; Kington, R.S.; Flaskerud, J.; Lewis, C.; Leake, B.; Gelberg, L. 1999: Two-year follow-up of AIDS education programs for impoverished women. Western Journal of Nursing Research 21(3): 405-425
Becerra, E.; Torres, H.; Gonzalez, R.; Borja, H.; Pedemonte, O.; de Prada, M.T.; Kaplan, J. 1993: Two-year follow-up of a heart transplant patient being treated with cyclosporine and ketoconazole. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 12(2): 338-340
Evans, R.; Bronfort, G.; Nelson, B.; Goldsmith, C.H. 2002: Two-year follow-up of a randomized clinical trial of spinal manipulation and two types of exercise for patients with chronic neck pain. Spine 27(21): 2383-2389
Tijhuis, G.J.; Zwinderman, A.H.; Hazes, J.M.W.; Breedveld, F.C.; Vlieland, P.M.T.V. 2003: Two-year follow-up of a randomized controlled trial of a clinical nurse specialist intervention, inpatient, and day patient team care in rheumatoid arthritis. Journal of Advanced Nursing 41(1): 34-43
Fhima, A.; Henrion, R.; Lowenstein, W.; Charpak, Y. 2001: Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex). Annales de Medecine Interne 152(Suppl 3): Is26-Is36
Grotemeyer, K.H.; Scharafinski, H.W.; Husstedt, I.W. 1993: Two-year follow-up of aspirin responder and aspirin non responder. a pilot-study including 180 post-stroke patients. Thrombosis Research 71(5): 397-403
McKay, D. 1999: Two-year follow-up of behavioral treatment and maintenance for body dysmorphic disorder. Behavior Modification 23(4): 620-629
Tarrier, N.; Kinney, C.; McCarthy, E.; Humphreys, L.; Wittkowski, A.; Morris, J. 2000: Two-year follow-up of cognitive--behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology 68(5): 917-922
Cao, J.P.; Zhang, L.Y.; Zhu, J.Q.; Chin, D.P. 1998: Two-year follow-up of directly-observed intermittent regimens for smear-positive pulmonary tuberculosis in China. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 2(5): 360-364
Marquez, I.M.; Fish, L.C.; Stella, J.P. 2000: Two-year follow-up of distraction osteogenesis: its effect on mandibular ramus height in hemifacial microsomia. American Journal of Orthodontics and Dentofacial Orthopedics: Official Publication of the American Association of Orthodontists its Constituent Societies and the American Board of Orthodontics 117(2): 130-139
Choi, S.Y.; Kim, H.Y.; Kim, J.Y.; Wee, W.R.; Lee, J.H. 1998: Two-year follow-up of eyes without topical corticosteroid treatment after photorefractive keratectomy (PRK). Korean Journal of Ophthalmology: Kjo 12(1): 25-29
Esquenazi, S.; Mendoza, A. 1999: Two-year follow-up of laser in situ keratomileusis for hyperopia. Journal of Refractive Surgery 15(6): 648-652
Ide; Kumashiro; Suzuki; Tanikawa; Sata 2000: Two-year follow-up study after treatment with lamivudine for chronic hepatitis B: seven cases reported. Hepatology Research: the Official Journal of the Japan Society of Hepatology 17(3): 197-204
Oshima, Y.; Yamanishi, S.; Sawa, M.; Motokura, M.; Harino, S.; Emi, K. 2000: Two-year follow-up study comparing primary vitrectomy with scleral buckling for macula-off rhegmatogenous retinal detachment. Japanese Journal of Ophthalmology 44(5): 538-549
Smedberg, J.I.; Ekenbäck, J.; Lothigius, E.; Arvidson, K. 1998: Two-year follow-up study of Procera-ceramic fixed partial dentures. International Journal of Prosthodontics 11(2): 145-149
Deblinger, E.; Steer, R.A.; Lippmann, J. 1999: Two-year follow-up study of cognitive behavioral therapy for sexually abused children suffering post-traumatic stress symptoms. Child Abuse and Neglect 23(12): 1371-1378
Ramos, L.R.; Toniolo, J.; Cendoroglo, M.S.; Garcia, J.T.; Najas, M.S.; Perracini, M.; Paola, C.R.; Santos, F.C.; Bilton, T.; Ebel, S.J.; Macedo, M.B.; Almada, C.M.; Nasri, F.; Miranda, R.D.; Gonçalves, M.; Santos, A.L.; Fraietta, R.; Vivacqua, I.; Alves, M.L.; Tudisco, E.S. 1998: Two-year follow-up study of elderly residents in S. Paulo, Brazil: methodology and preliminary results. Revista de saude publica 32(5): 397-407
Goldberg, L.C. 1994: Pretreatment of kidney allografts with monoclonal antibodies to CD45: results of a multicentre study. CD45 Study Group. Transplant International: Official Journal of the European Society for Organ Transplantation 7(Suppl 1): S252-S254
Lamminmäki, T.; Ahonen, T.; Todd de Barra, H.; Tolvanen, A.; Michelsson, K.; Lyytinen, H. 1997: Two-year group treatment for children with learning difficulties: assessing effects of treatment duration and pretreatment characteristics. Journal of Learning Disabilities 30(4): 354-364
Von Heimburg, D.; Pallua, N. 2001: Two-year histological outcome of facial lipofilling. Annals of Plastic Surgery 46(6): 644-646
Chavers, L.S.; Gilbert, G.H.; Shelton, B.J. 2003: Two-year incidence of oral disadvantage, a measure of oral health-related quality of life. Community Dentistry and Oral Epidemiology 31(1): 21-29
Slade, G.D.; Gansky, S.A.; Spencer, A.J. 1997: Two-year incidence of tooth loss among South Australians aged 60+ years. Community Dentistry and Oral Epidemiology 25(6): 429-437
Aas, H.N.; Leigh, B.C.; Anderssen, N.; Jakobsen, R. 1998: Two-year longitudinal study of alcohol expectancies and drinking among Norwegian adolescents. Addiction 93(3): 373-384
Henson, B.S.; Eisbruch, A.; D'Hondt, E.; Ship, J.A. 1999: Two-year longitudinal study of parotid salivary flow rates in head and neck cancer patients receiving unilateral neck parotid-sparing radiotherapy treatment. Oral Oncology 35(3): 234-241
Franchini, L.; Zanardi, R.; Gasperini, M.; Smeraldi, E. 1999: Two-year maintenance treatment with citalopram, 20 mg, in unipolar subjects with high recurrence rate. Journal of Clinical Psychiatry 60(12): 861-865
Vostanis, P.; Feehan, C.; Grattan, E. 1998: Two-year outcome of children treated for depression. European Child and Adolescent Psychiatry 7(1): 12-18
Aberg-Wistedt, A.; Cressell, T.; Lidberg, Y.; Liljenberg, B.; Osby, U. 1995: Two-year outcome of team-based intensive case management for patients with schizophrenia. Psychiatric Services 46(12): 1263-1266
Payne, R.G.; Kenny, D.J.; Johnston, D.H.; Judd, P.L. 1993: Two-year outcome study of zinc oxide-eugenol root canal treatment for vital primary teeth. Journal 59(6): 528
Cuffel, B.J.; Bloom, J.R.; Wallace, N.; Hausman, J.W.; Hu, T-wei. 2002: Two-year outcomes of fee-for-service and capitated medicaid programs for people with severe mental illness. Health Services Research 37(2): 341-359
Schanzlin, D.J.; Abbott, R.L.; Asbell, P.A.; Assil, K.K.; Burris, T.E.; Durrie, D.S.; Fouraker, B.D.; Lindstrom, R.L.; McDonald, J.E.; Verity, S.M.; Waring, G.O. 2001: Two-year outcomes of intrastromal corneal ring segments for the correction of myopia. Ophthalmology 108(9): 1688-1694
Baker, F.M.; Stokes-Thompson, J.; Davis, O.A.; Gonzo, R.; Hishinuma, E.S. 1999: Two-year outcomes of psychosocial rehabilitation of black patients with chronic mental illness. Psychiatric Services 50(4): 535-539
Kiremitçi, A.; Bolay, S.; Gürgan, S. 1998: Two-year performance of glass-ceramic insert-resin composite restorations: clinical and scanning electron microscopic evaluation. Quintessence International 29(7): 417-421
Castelo-Branco, C.; Casals, E.; Figueras, F.; Sanjuan, A.; Vicente, J.J.; Balasch, J.; Vanrell, J.A. 1999: Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins Ai and B. Menopause 6(2): 92-97
Lombardo, F.; Valenzise, M.; Wasniewska, M.; Messina, M.F.; Ruggeri, C.; Arrigo, T.; De Luca, F. 2002: Two-year prospective evaluation of the factors affecting honeymoon frequency and duration in children with insulin dependent diabetes mellitus: the key-role of age at diagnosis. Diabetes Nutrition and Metabolism 15(4): 246-251
Harvey, A.G.; Bryant, R.A. 2000: Two-year prospective evaluation of the relationship between acute stress disorder and posttraumatic stress disorder following mild traumatic brain injury. American Journal of Psychiatry 157(4): 626-628
Geller, B.; Craney, J.L.; Bolhofner, K.; Nickelsburg, M.J.; Williams, M.; Zimerman, B. 2002: Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. American Journal of Psychiatry 159(6): 927-933
Stadler, H.A.; Morrissey, J.; Rose, T.; Haley, S.; Trojahn, C.; Hampton, S. 1997: Patient capacity and judicial decisionmaking. Hec Forum: An Interdisciplinary Journal on Hospitals' Ethical and Legal Issues 9(3): 197-211
Lucas, D.O.; Zimmer, L.O.; Paul, J.E.; Jones, D.; Slatko, G.; Liao, W.; Lashley, J. 2001: Two-year results from the asthma self-management program: long-term impact on health care services, costs, functional status, and productivity. Journal of Asthma: Official Journal of the Association for the Care of Asthma 38(4): 321-330
Fries, J.F.; Bloch, D.A.; Harrington, H.; Richardson, N.; Beck, R. 1993: Two-year results of a randomized controlled trial of a health promotion program in a retiree population: the Bank of America Study. American Journal of Medicine 94(5): 455-462
Earnshaw, J.J.; Whitman, B.; Heather, B.P. 2000: Two-year results of a randomized controlled trial of rifampicin-bonded extra-anatomic dacron grafts. British Journal of Surgery 87(6): 758-759
Gillion, J.F.; Elhadad, A.; Balique, J.G.; Begin, G.F.; Fourtanier, G. 1996: Two-year results of celioscopic hernioplasties using an intraperitoneal ePTFE patch. a prospective multicenter study of 184 cases. Groupe CHIC (Cure des hernies inguinocrurales sous coelioscopie). Annales de Chirurgie 50(9): 799-802
Ozdamar, A.; Aras, C.; Sener, B.; Bahcecioglu, H. 1998: Two-year results of photorefractive keratectomy with scanning spot ablation for myopia of less than -6.0 diopters. Ophthalmic Surgery and Lasers 29(11): 904-908
Kreulen, C.M.; van Amerongen, W.E.; Akerboom, H.B.; Borgmeijer, P.J. 1995: Two-year results with box-only resin composite restorations. Asdc Journal of Dentistry for Children 62(6): 395-400
Anonymous 1999: Two-year review of Aged Care Act--final submission. Queensland nurse 18(4): 14
Niu, M.T.; Salive, M.; Krueger, C.; Ellenberg, S.S. 1998: Two-year review of hepatitis A vaccine safety: data from the Vaccine Adverse Event Reporting System (VAERS). Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 26(6): 1475-1476
Adamsons, I.A.; Polis, A.; Ostrov, C.S.; Boyle, J.E. 1998: Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group. Journal of Glaucoma 7(6): 395-401
Meyer, T.D.; Hautzinger, M. 1999: Two-year stability of Psychosis Proneness Scales and their relations to personality disorder traits. Journal of Personality Assessment 73(3): 472-488
Trull, T.J.; Useda, J.D.; Doan, B.T.; Vieth, A.Z.; Burr, R.M.; Hanks, A.A.; Conforti, K. 1998: Two-year stability of borderline personality measures. Journal of Personality Disorders 12(3): 187-197
Pesiri, A.J. 1994: Two-year study of the prevention of unintentional extubation. Critical Care Nursing Quarterly 17(3): 35-39
Tohen, M.; Hennen, J.; Zarate, C.M.; Baldessarini, R.J.; Strakowski, S.M.; Stoll, A.L.; Faedda, G.L.; Suppes, T.; Gebre-Medhin, P.; Cohen, B.M. 2000: Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. American Journal of Psychiatry 157(2): 220-228
Kazlauskaite, V.; Lynn, R. 2002: Two-year test-retest reliability of the colored progressive matrices. Perceptual and Motor Skills 95(2): 354
Vantrimpont, P.; Rouleau, J.L.; Ciampi, A.; Harel, F.; de Champlain, J.; Bichet, D.; Moyé, L.A.; Pfeffer, M. 1998: Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study. European Heart Journal 19(10): 1552-1563
D'Cruz, O.J.; Erbeck, D.; Waurzyniak, B.; Uckun, F.M. 2002: Two-year toxicity and carcinogenicity studies in B(6)C(3)F(1) mice with 5-bromo-6-methoxy-5,6-dihydro-3'-azidothymidine-5'-(p-bromophenyl) methoxyalaninyl phosphate (WHI-07), a novel anti-HIV and contraceptive agent. Toxicology 179(1-2): 61-77
Imbimbo, B.P.; Verdelli, G.; Martelli, P.; Marchesini, D. 1999: Two-year treatment of Alzheimer's disease with eptastigmine. the Eptastigmine Study Group. Dementia and Geriatric Cognitive Disorders 10(2): 139-147
Ceda, G.P.; Calbiani, B.; Maggio, M.; Perelli-Ercolini, S.; Benedetti, N.; Caporotundo, S.; Salimbeni, I.; Banchini, A.; Ugolotti, G.; Valenti, G. 1999: Two-year treatment with rhGH of one patient with chronic congestive heart failure and growth hormone deficiency. Journal of Endocrinological Investigation 22(10 Suppl): 51-52
Heresco-Levy, U.; Greenberg, D.; Lerer, B.; Dasberg, H.; Brown, W.A. 1995: Two-year trial of maintenance neuroleptic dose reduction in schizophrenic out-patients: predictors of relapse. Israel Journal of Psychiatry and Related Sciences 32(4): 268-275
Tysma, W.J.; Van Overbeek, M.C. 1994: On the way towards an automated system. Tvz: Het Vakblad Voor de Verpleging 104(12): 380-382
Cohen, S.; Cannon, G.W.; Schiff, M.; Weaver, A.; Fox, R.; Olsen, N.; Furst, D.; Sharp, J.; Moreland, L.; Caldwell, J.; Kaine, J.; Strand, V. 2001: Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Arthritis and Rheumatism 44(9): 1984-1992
Katz, B.; Radkowski, M.A.; De Leon, G.; McLone, D.G.; Sutton, L.N. 1997: Two-year-old boy with seizures. Pediatric Neurosurgery 27(3): 160-165
O'Neill, D.K.; Topolovec, J.C. 2001: Two-year-old children's sensitivity to the referential (in)efficacy of their own pointing gestures. Journal of Child Language 28(1): 1-28
Tan, R.K.; Melotti, M.; Comerci, S.C. 1999: Two-year-old girl with thymic calcifications and liver function abnormalities: a case from the A3CR2 film panel. Academic Radiology 6(10): 599-601
Book, D.T.; Flanary, V.A. 2001: Two-year-old with a persistent fetal vein presenting as a neck mass. Archives of Otolaryngology--Head and Neck Surgery 127(2): 206-208
Childers, J.B.; Tomasello, M. 2002: Two-year-olds learn novel nouns, verbs, and conventional actions from massed or distributed exposures. Developmental Psychology 38(6): 967-978
Mervis, C.B.; Golinkoff, R.M.; Bertrand, J. 1994: Two-year-olds readily learn multiple labels for the same basic-level category. Child Development 65(4): 1163-1177
Kemler Nelson, D.G.; Russell, R.; Duke, N.; Jones, K. 2000: Two-year-olds will name artifacts by their functions. Child Development 71(5): 1271-1288
Butler, S.C.; Berthier, N.E.; Clifton, R.K. 2002: Two-year-olds' search strategies and visual tracking in a hidden displacement task. Developmental Psychology 38(4): 581-590
Basile; Trombetta; Ferrante 1988: Twofold symmetric angular distributions in multiphoton ionization with elliptically polarized light. Physical Review Letters 61(21): 2435-2437
Székács, B.; Juhász, I.; Gachályi, B.; Fehér, J. 1993: TxA2-PGI2-PGF2 alfa responses in the kidney to blood pressure reduction induced by vasodilator/vasorelaxing agents with different action in patients with essential hypertension. Acta Physiologica Hungarica 81(4): 395-408
Lee, F.W.; Da Silva, N.A. 1996: Ty1-mediated integration of expression cassettes: host strain effects, stability, and product synthesis. Biotechnology Progress 12(4): 548-554
Yablonskiy 1991: Tyablikov approximation in the theory of low-dimensional quantum Heisenberg ferromagnets and antiferromagnets. Physical Review. B Condensed Matter 44(9): 4467-4472
Figala, D.; Brahe, T. 1972: Tycho Brahe's Elixier. Annals of Science 28: 139-176
Date, A. 2000: Tyger tyger. Journal of the Royal Society of Medicine 93(3): 160
Asplin, B.R. 2001: Tying a knot in the unraveling health care safety net. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine 8(11): 1075-1079
Tulloh, B.R. 1994: Tying an intracorporeal knot. Australian and New Zealand Journal of Surgery 64(5): 373-374
Lindquist, C.E. 1985: Tying hospital gifts to cost cutting incentives. Business and Health 2(6): 27-28
Becker, C. 2001: Tying it all together. Top tech vendors promote systems to link clinical and clerical departments. Modern Healthcare 31(35): 36-37
Czerenda, A.J.; Best, L. 1994: Tying it all together: integrating a hospital-based health care system through case management education. Journal of Case Management 3(2): 69-73; 87
Gagen, T.C.; Holsclaw, R.H. 1995: Tying outcomes to cost and quality. Health Management Technology 16(7): 26-27; 29
Britz, A.; Cushing, M.J.; Findley, P.P.; Head, S.; Gaul, N.; Holcomb, S.; Turnipseed, L. 1993: Tying pay to performance: one critical care unit's approach. Nursing Management 24(9): 112i-112j; 112n; 112p
Bledsoe, D.R.; Leisy, W.B.; Rodeghero, J.A. 1995: Tying physician incentive pay to performance. Healthcare Financial Management: Journal of the Healthcare Financial Management Association 49(12): 40-44
Reynolds, L. 1989: Tying retiree healthcare costs to the bottom line. Management Review 78(4): 54-55
Cowen, D.L. 1983: Tying the knot - secundum artem. New Jersey Journal of Pharmacy 56(3): 6
Takasaki, D.A. 1997: Tying the knot between resident care and quality of life. Balance 1(3): 16 18
Faber, J. 2000: Tying twin brackets. American Journal of Orthodontics and Dentofacial Orthopedics: Official Publication of the American Association of Orthodontists its Constituent Societies and the American Board of Orthodontics 118(1): 101-106
Shimoda, K.; Kato, K.; Aoki, K.; Matsuda, T.; Miyamoto, A.; Shibamori, M.; Yamashita, M.; Numata, A.; Takase, K.; Kobayashi, S.; Shibata, S.; Asano, Y.; Gondo, H.; Sekiguchi, K.; Nakayama, K.; Nakayama, T.; Okamura, T.; Okamura, S.; Niho, Y.; Nakayama, K. 2000: Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function. Immunity 13(4): 561-571
Elbadri, G.A.; Bert, W.; Geraert, E. 2001: Tylenchida associated with different crops in Sennar State (Sudan). Mededelingen 66(2b): 633-643
Haney, J.D. 1984: Tyler and Company/Southern Hospitals. 1984 salary and benefits survey. Southern Hospitals 52(5): 30-36
Lee, S.J.; Yun, B.S.; Cho, D.H.; Yoo, I.D. 1999: Tylopeptins a and B, new antibiotic peptides from Tylopilus neofelleus. Journal of Antibiotics 52(11): 998-1006
Gnabre, J.N.; Pinnas, J.L.; Bates, R.B.; Dolata, D.P.; Gangwar, S. 1993: Tylophora compounds as Na+/K(+)-ATPase inhibitors. General Pharmacology 24(5): 1107-1113
Wang, Q.; Xie, L.; Zhai, J. 2000: Tylophorine B benzene solvate. Acta Crystallographica. Section C Crystal Structure Communications 56: 197-198
Mandić, Z.; Naranda, A.; Lopotar, N.; Duić, L.; Iveković, D.; Tkalcec, M. 1999: Tylosin derivatives. V. Electrochemical opening of oxirane ring. Journal of Antibiotics 52(12): 1143-1145
Meisel, M.L.; Winterhoff, H.; Jekat, F.W. 1993: Tylosin inhibits the steroidogenesis in mouse Leydig cells "in vitro". Life Sciences 53(1): 77-84
Ellis, A.; Field, J.K.; Field, E.A.; Friedmann, P.S.; Fryer, A.; Howard, P.; Leigh, I.M.; Risk, J.; Shaw, J.M.; Whittaker, J. 1994: Tylosis associated with carcinoma of the oesophagus and oral leukoplakia in a large Liverpool family--a review of six generations. European Journal of Cancer. Part B Oral Oncology 30b (2): 102-112
Ghio, A.J.; Marshall, B.C.; Diaz, J.L.; Hasegawa, T.; Samuelson, W.; Povia, D.; Kennedy, T.P.; Piantodosi, C.A. 1996: Tyloxapol inhibits NF-kappa B and cytokine release, scavenges HOCI, and reduces viscosity of cystic fibrosis sputum. American Journal of Respiratory and Critical Care Medicine 154(3 Pt 1): 783-788
Robert, D.; Edgecomb, R.S.; Read, M.P.; Hoy, R.R. 1996: Tympanal hearing in tachinid flies (Diptera, Tachinidae, Ormiini): the comparative morphology of an innovation. Cell and Tissue Research 284(3): 435-448
Okura, T.; Nakano, Y.; Ikarashi, F. 1996: Tympanic bulla pneumatization following experimental mastoidectomy in a porcine animal model. Acta Oto-Laryngologica 116(4): 598-603
Frade González, C.; Lozano Ramírez, A.; Mínguez Beltrán, I.; Pérez-Carro, A.; Labella Caballero, T. 1998: Tympanic chemodectoma. A report of 2 cases. Anales Otorrinolaringologicos Ibero-Americanos 25(1): 77-84
Walsted, A.; Wagner, N.; Andersen, K.M.øl. 2002: Tympanic displacement analysis in healthy volunteers after indomethacin administration. Acta Oto-Laryngologica 122(8): 822-826
Hildmann, H.; Hildmann, A. 1993: Tympanic effusion. Hno 41(9): 455-464
Matsuura, K.; Tono, T.; Hara, Y.; Ueki, Y.; Ushisako, Y.; Morimitsu, T. 1996: Tympanic electrocochleography with disposable electrode. Nihon Jibiinkoka Gakkai Kaiho 99(7): 1016-1025
Rondini-Gilli, E.; Mosnier, I.; Gouin, J.M.; Aïdan, P.; Julien, N.; Rufat, P.; Sterkers, O. 2001: Tympanic grafts: surgical techniques and results of 260 cases. Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 118(2): 67-73
Kartush, J.M. 2000: Tympanic membrane Patcher: a new device to close tympanic membrane perforations in an office setting. American Journal of Otology 21(5): 615-620
Tekin, M.; Mutlu, C.; Paparella, M.M.; Schachern, P.A.; Jaisinghani, V.J.; Le, C.T. 2000: Tympanic membrane and middle ear pathologic correlates in mucoid otitis media. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 123(3): 258-262
Benecke, J.E. 2001: Tympanic membrane grafting with alloderm. Laryngoscope 111(9): 1525-1527
Ott, M.C.; Lundy, L.B. 2001: Tympanic membrane perforation in adults. How to manage, when to refer. Postgraduate Medicine 110(5): 81-84
McFeely, W.J.; Bojrab, D.I.; Kartush, J.M. 2000: Tympanic membrane perforation repair using AlloDerm. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 123(1 Part 1): 17-21
Laidlaw, D.W.; Costantino, P.D.; Govindaraj, S.; Hiltzik, D.H.; Catalano, P.J. 2001: Tympanic membrane repair with a dermal allograft. Laryngoscope 111(4 Part 1): 702-707
Moriya, K.; Sekitani, T.; Yamashita, H.; Mizokami, H. 1993: Tympanic membrane temperature in a patient with vertigo. Acta Oto-Laryngologica. Supplementum 506: 24-25
Briner, W.W. 1996: Tympanic membrane vs rectal temperature measurement in marathon runners. JAMA 276(3): 194
Jaisinghani, V.J.; Paparella, M.M.; Schachern, P.A.; Le, C.T. 1999: Tympanic membrane/middle ear pathologic correlates in chronic otitis media. Laryngoscope 109(5): 712-716
Vasama, J.P. 2000: Tympanic neurectomy and chronic parotitis. Acta Oto-Laryngologica 120(8): 995-998
Terndrup, T.E. 1994: Tympanic thermometers. Southern Medical Journal 87(10): 1059; Author Reply 1060-1
Norman, M.; Hägg, A.; Saastamoinen, V. 2002: Tympanic thermometers are of great value for health check ups of newborn infants. Lakartidningen 99(25): 2850-2852
Brogan, P.A. 1993: Tympanic thermometry: poor correlations. Clinical Pediatrics 32(11): 699-700
Schuman, A.J. 1991: Tympanic thermometry: temperatures without tears. Contemporary Pediatrics 8(Special Issue): 54-73
Yeo, S.; Hayashi, R.H.; Wan, J.Y.; Dubler, B. 1995: Tympanic versus rectal thermometry in pregnant women. Journal of Obstetric Gynecologic and Neonatal Nursing: Jognn 24(8): 719-724
Schilder, A.G.; Govaerts, P.J.; Somers, T.; Offeciers, F.E. 1997: Tympano-ossicular allografts for cholesteatoma in children. International Journal of Pediatric Otorhinolaryngology 42(1): 31-40
Culpepper, L. 2000: Tympanocentesis: to tap or not to tap. American Family Physician 61(7): 1987; 1990-1992
Arellano, B.; Ramírez-Camacho, R.; Pinilla, M.T.; García Berrocal, J.R. 1996: Tympanomastoid glomus tumor and persistent stapedial artery. Acta Otorrinolaringologica Espanola 47(6): 471-473
Sato, E.; Nakashima, T.; Lilly, D.J.; Fausti, S.A.; Ueda, H.; Misawa, H.; Uchida, Y.; Furuhashi, A.; Asahi, K.; Naganawa, S. 2002: Tympanometric findings in patients with enlarged vestibular aqueducts. Laryngoscope 112(9): 1642-1646
Gaihede, M.; Lambertsen, K.; Bramstoft, M.; Kamarauskas, A.; Fogh, A. 2000: Tympanometric hysteresis effect and errors in middle ear pressure determination--a preliminary study in children with secretory otitis media. Acta Oto-Laryngologica. Supplementum 543: 58-60
Wiley, T.L.; Cruickshanks, K.J.; Nondahl, D.M.; Tweed, T.S.; Klein, R.; Klein, B.E. 1996: Tympanometric measures in older adults. Journal of the American Academy of Audiology 7(4): 260-268
LaRossa, M.M.; Mitchell, S.; Cardinal, J.W. 1993: Tympanometry as a screening tool in the NICU: is it effective?. Neonatal Network: Nn 12(8): 33-35
Rasting, P.; Lindbaek, M. 1998: Tympanometry at a health center. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(22): 3426-3430
Johansen, E.C.; Lildholdt, T.; Damsbo, N.; Eriksen, E.W. 2000: Tympanometry for diagnosis and treatment of otitis media in general practice. Family Practice 17(4): 317-322
Holsgrove, G. 1993: Tympanometry in general practice. Practitioner 237(1528): 547-548; 551
Green, L.A.; Culpepper, L.; de Melker, R.A.; Froom, J.; van Balen, F.; Grob, P.; Heeren, T. 2000: Tympanometry interpretation by primary care physicians. A report from the International Primary Care Network (IPCN) and the Ambulatory Sentinel Practice Network (ASPN). Journal of Family Practice 49(10): 932-936
Kazanas, S.G.; Maw, A.R. 1994: Tympanometry, stapedius reflex and hearing impairment in children with otitis media with effusion. Acta Oto-Laryngologica 114(4): 410-414
Konarska, A. 1998: Tympanoplasty after radical operation. Otolaryngologia Polska 52(4): 457-462
Sprem, N.; Branica, S.; Dawidowsky, K. 2001: Tympanoplasty after war blast lesions of the eardrum: retrospective study. Croatian Medical Journal 42(6): 642-645
Legent, F.; Sourdille, M. 2000: Tympanoplasty and Sourdille. Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 117(4): 215-219
Yu, L.H.; Lien, C.F. 1998: Tympanoplasty for pars flaccida. Zhonghua Yi Xue Za Zhi 61(8): 479-483
Iashan, A.I. 2001: Tympanoplasty for patients with destruction of the stapes. Vestnik Otorinolaringologii 3: 58-60
Podoshin, L.; Fradis, M.; Malatskey, S.; Ben-David, J. 1996: Tympanoplasty in adults: a five-year survey. Ear Nose and Throat Journal 75(3): 149-152; 155-156
Bajaj, Y.; Bais, A.S.; Mukherjee, B. 1998: Tympanoplasty in children--a prospective study. Journal of Laryngology and Otology 112(12): 1147-1149
Sakagami, M.; Kitamura, K.; Doi, K.; Mishiro, Y.; Kubo, T. 1994: Tympanoplasty in cholesteatoma otitis media with normal hearing. Nihon Jibiinkoka Gakkai Kaiho 97(8): 1437-1442
Lacher, G.; Négrevergne, M. 1996: Tympanoplasty in clinical practice: use and results. Revue de Laryngologie - Otologie - Rhinologie 117(3): 241-245
Radpour, S. 1999: Tympanoplasty in geriatric patients: surgical considerations. Ear Nose and Throat Journal 78(7): 484; 488
Vartiainen, E.; Vartiainen, J. 1997: Tympanoplasty in young patients: the role of adenoidectomy. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 117(6): 583-585
Gardner, E.; Dornhoffer, J.L. 2002: Tympanoplasty results in patients with cleft palate: an age- and procedure-matched comparison of preliminary results with patients without cleft palate. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 126(5): 518-523
Häusler, R. 1999: Tympanoplasty today: facts, hypotheses and controversies. Hno 47(1): 2-5
Park, M.S. 1995: Tympanoplasty using autologous crushed cartilage. Revue de Laryngologie - Otologie - Rhinologie 116(5): 365-368
Amorós Sebastiá, L.I.; Murcia Puchades, V.; Dalmau Galofre, J.; Carrasco Llatas, M.; López Mollá, C.; López Martínez, R. 2002: Tympanoplasty using cartilage: 3 years of experience. Acta otorrinolaringologica espanola 53(8): 578-582
Roger, G.; Bokowy, C.; Coste, A.; Moine, A.; Monier, S.; Florant, A.; Roulleau, P. 1994: Tympanoplasty using chondro-perichondral graft. Indications, techniques and results. Apropos of a series of 127 cases. Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 111(1): 29-34
Kjeldsen, A.D.; Grøntved, A.M. 2000: Tympanoplasty with ionomeric cement. Acta Oto-Laryngologica. Supplementum 543: 130-131
Popko, E.; Chodynicki, S.ła. 2002: Tympanoplasty with the use of autologous tissue. Otolaryngologia Polska 56(4): 475-478
Gersdorff, M.C.H.; Gérard, J.-M. 2002: Tympanoplasty without skin incision of the external auditory canal. Laryngoscope 112(8 Part 1): 1507-1508
Russell, J.D.; Giles, J.J. 2002: Tympanosclerosis in the rat tympanic membrane: an experimental study. Laryngoscope 112(9): 1663-1666
Ramírez Camacho, R.; Trinidad, A.; Vicente, J.; Herrero, J. 1999: Tympanosclerosis. I: proposed anatomical-surgical classification. Acta Otorrinolaringologica Espanola 50(1): 6-8
Louryan, S.; Choufani, G.; Tainmont, J.; Hassid, S. 1999: Tympanosclerosis. Radio-anatomic correlation. Revue Medicale de Bruxelles 20(2): A101-A103
Santos Santos, S.; Hernández García, M.J.; Ordóñez Martínez, F.; Olaizola Gorbea, F. 1997: Tympanosclerosis. Review of 138 cases. Acta Otorrinolaringologica Espanola 48(6): 452-456
Teufert, K.B.; De La Cruz, A. 2002: Tympanosclerosis: long-term hearing results after ossicular reconstruction. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 126(3): 264-272
Asiri, S.; Hasham, A.; al Anazy, F.; Zakzouk, S.; Banjar, A. 1999: Tympanosclerosis: review of literature and incidence among patients with middle-ear infection. Journal of Laryngology and Otology 113(12): 1076-1080
Urben, S.L.; Nichols, R.D. 1996: Tympanostomies with tubes: the parent perspective. Laryngoscope 106(10): 1269-1273
François, M.; Mariani-Kurkdjian, P.; Doit, C.; Benzekri, P.; Bingen, E.; Macé, J.G. 2001: Tympanostomy tube otorrhea: microbiological epidemiology, pathogen susceptibility to local antibiotics and bactericidal power of the rifamycin-olfloxacin combination. Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 118(5): 278-282
Goode, R.L. 1993: Tympanostomy tube removal. Laryngoscope 103(11 Pt 1): 1305-1307
Anonymous 1993: Tympanostomy tubes and audiograms. Archives of Otolaryngology--Head and Neck Surgery 119(4): 370-371
Smyth, G.D.; Patterson, C.C.; Hall, S. 1982: Tympanostomy tubes: do they significantly benefit the patient?. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 90(6): 783-786
Cunningham, M.J.; Eavey, R.D.; Krouse, J.H.; Kiskaddon, R.M. 1993: Tympanostomy tubes: experience with removal. Laryngoscope 103(6): 659-662
Guex-Crosier, Y.; Cassoux, N.; Fardeau, C.; Lehoang, P.; Herbort, C.P. 1997: Tyndall automatized photometry (PAT) in ophthalmology. Journal Francais d'Ophtalmologie 20(5): 391-404
Küchle, M.; Nguyen, N.X.; Naumann, G.O. 1994: Tyndallometry with the laser flare cell meter in intraocular inflammation. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 91(2): 219-223
Juneja, R.; Palmer, J.P. 1999: Type 1 1/2 diabetes: myth or reality?. Autoimmunity 29(1): 65-83
Davani, B.; Khan, A.; Hult, M.; Mårtensson, E.; Okret, S.; Efendic, S.; Jörnvall, H.; Oppermann, U.C. 2000: Type 1 11beta -hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets. Journal of Biological Chemistry 275(45): 34841-34844
Colli, R.; Colombo, P.; Russo, F.; Sterpa, A. 2001: Type 1 Arnold Chiari malformation in a subject with Noonan syndrome. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 23(1): 61-64
Chen, C.C.; Chiu, P.C.; Shieh, K.S. 1999: Type 1 GM1 gangliosidosis with basal ganglia calcification: a case report. Zhonghua Yi Xue Za Zhi 62(1): 40-45
García, M.; Casanova, C.; Chabás, A.; Viosca, E.; Martínez, B. 1997: Type 1 Gaucher disease in a pediatric patient: 12 year's evolution. Sangre 42(3): 227-229
Ida, H.; Rennert, O.M.; Ito, T.; Maekawa, K.; Eto, Y. 1998: Type 1 Gaucher disease: phenotypic expression and natural history in Japanese patients. Blood Cells Molecules and Diseases 24(1): 73-81
Montaner, L.J.; da Silva, R.P.; Sun, J.; Sutterwala, S.; Hollinshead, M.; Vaux, D.; Gordon, S. 1999: Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-gamma or IL-10. Journal of Immunology 162(8): 4606-4613
Fallon, P.G.; Smith, P.; Dunne, D.W. 1998: Type 1 and type 2 cytokine-producing mouse CD4+ and CD8+ T cells in acute Schistosoma mansoni infection. European Journal of Immunology 28(4): 1408-1416
Murphy, J.W.; Bistoni, F.; Deepe, G.S.; Blackstock, R.A.; Buchanan, K.; Ashman, R.B.; Romani, L.; Mencacci, A.; Cenci, E.; Fè d'Ostiani, C.; Del Sero, G.; Calich, V.L.; Kashino, S.S. 1998: Type 1 and type 2 cytokines: from basic science to fungal infections. Medical Mycology 36(Suppl 1): 109-118
Nicodemus, K.K.; Folsom, A.R. 2001: Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 24(7): 1192-1197
Obana, M.; Matsuoka, Y. 1999: Type 1 and type 2 health facilities specified for the control of infections. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 88(11): 2117-2122
Wedderburn, L.R.; Woo, P. 1999: Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis. Springer Seminars in Immunopathology 21(3): 361-374
Rogers, K.A.; DeKrey, G.K.; Mbow, M.L.; Gillespie, R.D.; Brodskyn, C.I.; Titus, R.G. 2002: Type 1 and type 2 responses to Leishmania major. Fems Microbiology Letters 209(1): 1-7
Saridogan, E.; Djahanbakhch, O.; Puddefoot, J.R.; Demetroulis, C.; Dawda, R.; Hall, A.J.; Vinson, G.P. 1996: Type 1 angiotensin Ii receptors in human endometrium. Molecular Human Reproduction 2(9): 659-664
Kosar, Y.; Kacar, S.; Sasmaz, N.; Oguz, P.; Turhan, N.; Parlak, E.; Heneghan, M.A.; McFarlane, I.G. 2002: Type 1 autoimmune hepatitis in Turkish patients: absence of association with HLA B8. Journal of Clinical Gastroenterology 35(2): 185-190
Stellato, G.; Nieminen, P.; Aho, M.; Lehtinen, T.; Lehtinen, M.; Paavonen, J. 1997: Type 1 cytokine response and treatment outcome of genital HPV lesions. Genitourinary Medicine 73(5): 387-390
Lernmark, A. 1999: Type 1 diabetes. Clinical Chemistry 45(8 Part 2): 1331-1338
Woo, K.S.; Chook, P.; Chan, W.B.; So, W.Y.; Cockram, C.S.; Celermajer, D.S. 2001: Type 1 diabetes and arterial dysfunction in asymptomatic Chinese adults. Diabetes Care 24(1): 173
Krokowski, M.; Abel, M.; Teodorczyk, A.; Szadkowska, A.; Pyrzak, B.; Rymkiewicz-Kluczyńska, B.; Bodalski, J. 1998: Type 1 diabetes and prediabetic state in a monozygotic triplet. Acta Geneticae Medicae et Gemellologiae 47(3-4): 171-176
Weintrob, N.; Sprecher, E.; Israel, S.; Pinhas-Hamiel, O.; Kwon, O.J.; Bloch, K.; Abramov, N.; Arbel, A.; Josefsberg, Z.; Brautbar, C.; Vardi, P. 2001: Type 1 diabetes environmental factors and correspondence analysis of HLA class II genes in the Yemenite Jewish community in Israel. Diabetes Care 24(4): 650-653
O'Brien, C. 1996: Type 1 diabetes gets the genomics treatment. Molecular Medicine Today 2(9): 360
Sebastiani, L.; Visalli, N.; Adorisio, E.; D'Elia, R.; Conte, A.; Pozzilli, P. 2001: Type 1 diabetes in Lazio. Note 2 -- case control study of risk factors. Annali di Igiene: Medicina Preventiva e di Comunita 13(6): 523-530
Kolar, K.R.; Haynie, L.; Wilkerson, R.; Fisher, W. 2002: Type 1 diabetes in children and adolescents: what's new?. Journal of School Nursing: the Official Publication of the National Association of School Nurses 18(3): 144-149
Willis, J.; Scott, R.; Brown, L.; Zimmet, P.; MacKay, I.; Rowley, M. 1998: Type 1 diabetes in insulin-treated adult-onset diabetic subjects. Diabetes Research and Clinical Practice 42(1): 49-53
Casu, A.; Carlini, M.; Contu, A.; Bottazzo, G.F.; Songini, M. 2000: Type 1 diabetes in sardinia is not linked to nitrate levels in drinking water. Diabetes Care 23(7): 1043-1044
Anwar, A.J.; Walker, J.D.; Frier, B.M. 1998: Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications. Diabetic Medicine: a Journal of the British Diabetic Association 15(2): 160-163
Olson, J.A.; Olson, D.M.; Sandborg, C.; Alexander, S.; Buckingham, B. 2002: Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies. Pediatrics 109(3): E50
McGrath, N.M.; Yeong, M.L. 2000: Type 1 diabetes mellitus and hepatic sinusoidal fibrosis. Diabetic Medicine: a Journal of the British Diabetic Association 17(1): 87-88
Koike, T. 2002: Type 1 diabetes mellitus and immunopathology. Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 7): 399-406
Moore, P.A.; Weyant, R.J.; Etzel, K.R.; Guggenheimer, J.; Mongelluzzo, M.B.; Myers, D.E.; Rossie, K.; Hubar, H.; Block, H.M.; Orchard, T. 2001: Type 1 diabetes mellitus and oral health: assessment of coronal and root caries. Community Dentistry and Oral Epidemiology 29(3): 183-194
Moore, P.A.; Weyant, R.J.; Mongelluzzo, M.B.; Myers, D.E.; Rossie, K.; Guggenheimer, J.; Hubar, H.; Block, H.M.; Orchard, T. 1998: Type 1 diabetes mellitus and oral health: assessment of tooth loss and edentulism. Journal of Public Health Dentistry 58(2): 135-142
Hirsch, I.B. 1999: Type 1 diabetes mellitus and the use of flexible insulin regimens. American Family Physician 60(8): 2343-2352; 2355-2356
Cinek, O.; Lánská, V.; Kolousková, S.; Sumník, Z.; Snajderová, M.; Rønningen, K.S.; Vavrinec, J. 2000: Type 1 diabetes mellitus in Czech children diagnosed in 1990-1997: a significant increase in incidence and male predominance in the age group 0-4 years. Collaborators of the Czech Childhood Diabetes Registry. Diabetic medicine: a journal of the British Diabetic Association 17(1): 64-69
Gonc, E.N.; Ozon, A.; Alikasifoglu, A.; Kandemir, N. 2002: Type 1 diabetes mellitus in a 3 1/2 year-old girl with Turner's syndrome. Journal of Pediatric Endocrinology and Metabolism: Jpem 15(8): 1203-1206
Pawar, B.K.; Walford, S.; Singh, B.M. 1999: Type 1 diabetes mellitus in a routine diabetes clinic: the association of psycho-social factors, diabetes knowledge and glycaemic control to insulin regime. Diabetes Research and Clinical Practice 46(2): 121-126
Ogle, G.D.; Lesley, J.; Sine, P.; McMaster, P. 2001: Type 1 diabetes mellitus in children in Papua new Guinea. Papua and new Guinea Medical Journal 44(3-4): 96-100
Andĕl, M.; Kucera, P.; Treslová, L.; Perusicová, J.; Karlová, V.; Richterová, A.; Potocková, J. 1998: Type 1 diabetes mellitus in the aged. Vnitrni Lekarstvi 44(4): 232-236
Hummel, M.; Ziegler, A.G.; Bonifacio, E. 2001: Type 1 diabetes mellitus, celiac disease and their association--lessons from antibodies. Journal of Pediatric Endocrinology and Metabolism: Jpem 14 Suppl. 1: 607-610
O'Connor, T.M.; Cronin, C.C.; Loane, J.F.; O'Meara, N.M.; Firth, R.G.; Shanahan, F.; O'Halloran, D.J. 1999: Type 1 diabetes mellitus, coeliac disease, and lymphoma: a report of four cases. Diabetic Medicine: a Journal of the British Diabetic Association 16(7): 614-617
Mandrup-Poulsen, T.R. 2002: Type 1 diabetes mellitus--an infectious disease?. Ugeskrift for Laeger 164(50): 5936-5940
Kawaguchi, Y.; Ikegami, H.; Ogihara, T. 1997: Type 1 diabetes susceptibility genes on human chromosome 2q. Nihon Rinsho. Japanese Journal of Clinical Medicine 55 Suppl: 392-396
Mohatt, J.; Gilliam, L.K.; Bekris, L.; Ebbesson, S.; Lernmark, A. 2002: Type 1 diabetes-related autoantibodies are rare in Alaska native populations. International Journal of Circumpolar Health 61(1): 21-31
Anonymous 2002: Type 1 diabetes: benefits of intensive insulin therapy. Patients should control blood glucose strictly. Prescrire International 11(58): 61
Lunt, H.; Kendall, D.; Moore, M.P.; Owens, N.; Cole, D.R.; Willis, J.A.; Scott, R.S.; Darlow, B.A. 2002: Type 1 diabetes: glycaemic control during adolescence. New Zealand Medical Journal 115(1167): U282
Roep, B.O. 2002: Type 1 diabetes: how to resist a fatal attraction. Netherlands Journal of Medicine 60(7): 296-297
Letonturier, P. 2000: Type 1 diabetes: long-term effects of intensive insulin therapy on diabetic retinopathy and nephropathy. Presse Medicale 29(11): 598
Mathieu, C.; Decallonne, B.; Casteels, K. 2000: Type 1 diabetes: origin and possibilities for prevention. Verhandelingen-KoninklijkeAcademieVoorGeneeskundevanBelgie 62(5): 423
Yonemoto, T.; Nishikawa, M.; Matsubara, H.; Mori, Y.; Toyoda, N.; Gondou, A.; Imai, Y.; Iwasaka, T.; Inada, M. 1999: Type 1 iodothyronine deiodinase in heart --effects of triiodothyronine and angiotensin Ii on its activity and mRNA in cultured rat myocytes. Endocrine Journal 46(5): 621-628
Devaux, J.P.; Andrieux, S.; Melliez, H.; Copin, M.C.; Azar, R. 2001: Type 1 membranoproliferative glomerulonephritis in a patient with acquired partial lipodystrophy. Presse Medicale 30(16): 790-791
Paja Fano, M.; Goñi Goicoechea, F.; Yoldi Arrieta, A.; Ramón Elorza Olabegoya, J. 2001: Type 1 multiple endocrine neoplasia associated to thymic carcinoid. Clinical and genetic study of one case. Medicina Clinica 116(1): 39
Gouider, R.; Azaiz, M.I.; Kchouk, M.; Lasram, L.; Ben Osman, A.; Mrabet, A. 1994: Type 1 neurofibromatosis in Tunisia: 66 cases. Annales de Dermatologie et de Venereologie 121(2): 185-189
Fernández-Jaén, A.; Calleja-Pérez, B.; Viaño-López, J.; Sánchez, C.; Anciones, B. 2001: Type 1 neurofibromatosis, epilepsy and disorders of neuronal migration. Revista de Neurologia 33(6): 593-595
Schweigerer, L. 1996: Type 1 neurofibromatosis. Molecular and clinical aspects. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 47(8): 591-598
Madalena, C.; Pereira, S.A.; Rosário, C.; Santos, M.; Barbot, C. 2001: Type 1 neurofibromatosis: the experience of a hospital in Porto, Portugal. Revista de Neurologia 33(8): 794-795
Hess, P.; Daryab, N.; Michaelis, K.; Reisenauer, A.; Oelschlaeger, T.A. 2000: Type 1 pili of Citrobacter freundii mediate invasion into host cells. Advances in Experimental Medicine and Biology 485: 225-235
Suo, Z.; Yang, H.; Mei, Q.; Skovlund, E.; Cui, J.; Nesland, J.M. 2001: Type 1 protein tyrosine kinases in Chinese breast carcinomas: a clinicopathologic study. International Journal of Surgical Pathology 9(3): 177-187
Bwire, R.; Kawuma, H.J. 1994: Type 1 reactions in leprosy, neuritis and steroid therapy: the impact of the human immunodeficiency virus. Transactions of the Royal Society of Tropical Medicine and Hygiene 88(3): 315-316
Lang, K.; Reifenberger, J.; Ruzicka, T.; Megahed, M. 2002: Type 1 segmental cutaneous leiomyomatosis. Clinical and Experimental Dermatology 27(8): 649-650
Akbiyik, F.; Balci, S.; Akkoyun, I.; Aktaş, D.; Cakmak, O. 2000: Type 1 sirenomelia in one of male twins, with imperforate anus in the other male twin. Clinical Dysmorphology 9(3): 227-229
Aruga, A.; Aruga, E.; Tanigawa, K.; Bishop, D.K.; Sondak, V.K.; Chang, A.E. 1997: Type 1 versus type 2 cytokine release by Vbeta T cell subpopulations determines in vivo antitumor reactivity: IL-10 mediates a suppressive role. Journal of Immunology 159(2): 664-673
Bohannon, N.J. 2001: Type 1 versus type 2 diabetes: still a useful distinction?. Postgraduate Medicine 110(2): 23-24
Scherbaum, W.A. 2001: Type 1, type 2 diabetes, MODY and LADA. Making a differential diagnosis. MMW Fortschritte der Medizin 143(37): 45-48
Jund, E. 2000: Care for the diabetic patient. Role of the occupational health nurse. Revue de l'Infirmiere 59: 33-34
Verhagen, C.E.; van der Pouw Kraan, T.C.; Buffing, A.A.; Chand, M.A.; Faber, W.R.; Aarden, L.A.; Das, P.K. 1998: Type 1- and type 2-like lesional skin-derived Mycobacterium leprae-responsive T cell clones are characterized by coexpression of IFN-gamma/TNF-alpha and IL-4/IL-5/IL-13, respectively. Journal of Immunology 160(5): 2380-2387
Kawakami, K.; Owan, I.; Kaneshima, H.; Saito, A. 1995: Type 1-like helper T cell lines responsive to autologous peripheral blood monocytes established from two patients with sarcoidosis. Sarcoidosis 12(2): 111-117
Devoize, J.L.; Hermes, I.; Texier, J.C.; d'Dong, M.; Prat, C.; Pin, J.C. 1997: Type 12 F Streptococcus pneumoniae meningitis in a splenectomized patient: failure of vaccination. Presse Medicale 26(29): 1385
Stewart, P.M.; Whorwood, C.B.; Mason, J.I. 1995: Type 2 11 beta-hydroxysteroid dehydrogenase in foetal and adult life. Journal of Steroid Biochemistry and Molecular Biology 55(5-6): 465-471
Stewart, P.M.; Murry, B.A.; Mason, J.I. 1994: Type 2 11 beta-hydroxysteroid dehydrogenase in human fetal tissues. Journal of Clinical Endocrinology and Metabolism 78(6): 1529-1532
Combarros-Pascual, O. 2000: Type 2 Charcot-Marie-Tooth disease?. Revista de Neurologia 30(1): 79-81
Clouet, F.; Excler-Cavailher, G.; Christophe, B.; Masson, F.; Fasquel, D. 2001: Type 2 Diabetes and Short Form 36-items Health Survey. Diabetes and Metabolism 27(6): 711-717
Reissner, K.; Tayebi, N.; Stubblefield, B.K.; Koprivica, V.; Blitzer, M.; Holleran, W.; Cowan, T.; Almashanu, S.; Maddalena, A.; Karson, E.M.; Sidransky, E. 1998: Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus. Molecular Genetics and Metabolism 63(4): 281-288
Choy, F.Y. 1995: Type 2 Gaucher disease without the "complex alleles". Journal of Clinical Laboratory Analysis 9(5): 340-341
Stone, D.L.; Carey, W.F.; Christodoulou, J.; Sillence, D.; Nelson, P.; Callahan, M.; Tayebi, N.; Sidransky, E. 2000: Type 2 Gaucher disease: the collodion baby phenotype revisited. Archives of Disease in Childhood. Fetal and Neonatal Edition 82(2): F163-F166
Becker, B.N.; Jacobson, L.M.; Hullett, D.A.; Radke, N.A.; Oberley, T.D.; Brazy, P.C.; Kirk, A.D. 2002: Type 2 angiotensin II receptor expression in human renal allografts: an association with chronic allograft nephropathy. Clinical Nephrology 57(1): 19-26
Leri, O.; Paparo Barbaro, S.; Sinopoli, M.T.; Marcelli, V.; De Rosa, F.G.; De Luca, D. 1996: Type 2 autoimmune hepatitis and hepatitis C viraemia. Rivista Europea Per le Scienze Mediche e Farmacologiche 18(1): 3-6
Taylor, S.C.; Shacks, S.J.; Qu, Z.; Wiley, P. 1997: Type 2 cytokine serum levels in healthy sickle cell disease patients. Journal of the National Medical Association 89(11): 753-757
Tallis, G.A.; Phillips, P.J.; Popplewell, P.Y. 1997: Type 2 diabetes. Australian Family Physician 26(5): 609-610
Vibe-Petersen, J.; Perrild, H.J. 2000: Type 2 diabetes among immigrants. Ugeskrift for Laeger 162(46): 6220-6222
Waldecker, B.; Waas, W.; Haberbosch, W.; Voss, R.; Steen-Müller, M.K.; Hiddessen, A.; Bretzel, R.; Tillmanns, H. 1999: Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients. Diabetes Care 22(11): 1832-1838
Donnelly, R.; Davis, K.R. 2000: Type 2 diabetes and atherosclerosis. Diabetes Obesity and Metabolism 2(Suppl 1): S21-S30
Cerasi, E.; Kaiser, N.; Leibowitz, G. 2000: Type 2 diabetes and beta cell apoptosis. Diabetes and Metabolism 26(Suppl 3): 13-16
Barnett, A. 2001: Type 2 diabetes and cardiovascular disease. Nursing Times 97(5): 33-35
Lièvre, M. 2001: Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials. La Revue du Praticien 51(16): 1793-1799
Strachan, M.W.J.; Frier, B.M.; Deary, I.J. 2003: Type 2 diabetes and cognitive impairment. Diabetic Medicine: a Journal of the British Diabetic Association 20(1): 1-2
Viswanathan, V. 1999: Type 2 diabetes and diabetic nephropathy in India--magnitude of the problem. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 14(12): 2805-2807
Segal, P. 1999: Type 2 diabetes and large vessel disease. Diabetes and Metabolism 25(Suppl 7): 7-10
Bjørnholt, J.V.; Erikssen, G.; Liestøl, K.; Jervell, J.; Thaulow, E.; Erikssen, J. 2000: Type 2 diabetes and maternal family history: an impact beyond slow glucose removal rate and fasting hyperglycemia in low-risk individuals? Results from 22.5 years of follow-up of healthy nondiabetic men. Diabetes care 23(9): 1255-1259
Os, I.; Stenehjem, A.; Høieggen, A.; Draganov, B.; Jenssen, T.; Holdaas, H. 2002: Type 2 diabetes and nephropathy--new studies, new treatment strategies?. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 122(9): 918-920
Anonymous 2000: Type 2 diabetes and public health: how to cure it. Revue de l'infirmiere 2000(59): 28
Valle, T.T.; Lindström, J.; Eriksson, J.G.; Uusitupa, M.; Tuomilehto, J. 2001: Type 2 diabetes can be prevented by life style changes. Duodecim; Laaketieteellinen Aikakauskirja 117(15): 1517-1518
Pinhas-Hamiel, O.; Zeitler, P. 1998: Type 2 diabetes in adolescents, no longer rare. Pediatrics in Review 19(12): 434-435
Wu, C.J.; Sheu, W.H. 1998: Type 2 diabetes in adults with pseudopseudohypoparathyroidism. Case report. Diabetes Care 21(9): 1575-1576
Chronister, C.L.; Gurwood, A.S. 1998: Type 2 diabetes in association with HIV-1 protease inhibitors in HIV-infected patients. Journal of the American Optometric Association 69(11): 695-698
Howdle, S.; Wilkin, T. 2001: Type 2 diabetes in children. Nursing Standard: 15(18): 38-42
Anonymous 2000: Type 2 diabetes in children and adolescents. American Diabetes Association. Pediatrics 105(3 Pt 1): 671-680
Brosnan, C.A.; Upchurch, S.; Schreiner, B. 2001: Type 2 diabetes in children and adolescents: an emerging disease. Journal of Pediatric Health Care: Official Publication of National Association of Pediatric Nurse Associates and Practitioners 15(4): 187-193
Bobo, N. 2002: Type 2 diabetes in children and adolescents: information from the National Diabetes Education Program. Nasnewsletter 17(4): 13-14
Narayan, K.M.; Fagot-Campagna, A.; Imperatore, G. 2001: Type 2 diabetes in children: a problem lurking for India?. Indian Pediatrics 38(7): 701-704
Franse, L.V.; Di Bari, M.; Shorr, R.I.; Resnick, H.E.; van Eijk, J.T.; Bauer, D.C.; Newman, A.B.; Pahor, M. 2001: Type 2 diabetes in older well-functioning people: who is undiagnosed? Data from the Health, Aging, and Body Composition study. Diabetes Care 24(12): 2065-2070
Hosey, G.; Gordon, S.; Levine, A. 1998: Type 2 diabetes in people of color. Nurse Practitioner Forum 9(2): 108-114
Kutty, V.R.; Soman, C.R.; Joseph, A.; Pisharody, R.; Vijayakumar, K. 2000: Type 2 diabetes in southern Kerala: variation in prevalence among geographic divisions within a region. National Medical Journal of India 13(6): 287-292
Anonymous 2001: Type 2 diabetes in women. Harvard Women's Health Watch 8(11): 4-5
Dean, H. 2001: Type 2 diabetes in youth: a new epidemic. Advances in Experimental Medicine and Biology 498: 1-5
Moore, P. 2000: Type 2 diabetes is a major drain on resources. Bmj 320(7237): 732
Saitoh, T.; Daimon, M.; Eguchi, H.; Hosoya, T.; Kawanami, T.; Kurita, K.; Tominaga, M.; Kato, T. 2002: Type 2 diabetes is not a risk factor for asymptomatic ischemic brain lesion--the Funagata study. Internal Medicine 41(5): 351-356
Bektas, A.; Hughes, J.N.; Warram, J.H.; Krolewski, A.S.; Doria, A. 2001: Type 2 diabetes locus on 12q15. Further mapping and mutation screening of two candidate genes. Diabetes 50(1): 204-208
Nelson, G. 2002: Type 2 diabetes management. British Journal of Community Nursing 7(1): 5
Moghissi, E.; Mestman, J. 2000: Type 2 diabetes mellitus. Diabetes Technology and Therapeutics 2(Suppl 1): S61-S65
Auleley, G-R.; Dematons, M.N.; Berchery, P.; Raynal-Minville, F.; Suarez, F.; Heuls-Bernin, B.; Blum-Boisgard, C. 2002: Type 2 diabetes mellitus among beneficiaries of the french national health insurance for self-employed workers (AMPI): comparison of the management of craftsmen or tradesmen with professionals patients. Diabetes and Metabolism 28(6 Pt 1): 491-498
Bell, D. 1998: Type 2 diabetes mellitus and Aboriginal Australians. Options for oral therapy in the control of glyceamia. Australian Family Physician 27(11): 1017-1020
Shah, D.; Turnbull, C.J. 2002: Type 2 diabetes mellitus and thyrotoxicosis presenting concurrently. International Journal of Clinical Practice 56(9): 701-703
Young, T.K.; Reading, J.; Elias, B.; O'Neil, J.D. 2000: Type 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress. Cmaj: Canadian Medical Association Journal 163(5): 561-566
Kim, C.; McHugh, C.; Kwok, Y.; Smith, A. 1999: Type 2 diabetes mellitus in Navajo adolescents. Western Journal of Medicine 170(4): 210-213
Ogle, G.D. 2001: Type 2 diabetes mellitus in Papua new Guinea--an historical perspective. Papua and new Guinea Medical Journal 44(3-4): 81-87
Ehtisham, S.; Barrett, T.G.; Shaw, N.J. 2000: Type 2 diabetes mellitus in UK children--an emerging problem. Diabetic Medicine: a Journal of the British Diabetic Association 17(12): 867-871
Laron, Z. 2002: Type 2 diabetes mellitus in childhood--a global perspective. Journal of Pediatric Endocrinology and Metabolism: Jpem 15(Suppl 1): 459-469
Kaufman, F.R. 2002: Type 2 diabetes mellitus in children and youth: a new epidemic. Journal of Pediatric Endocrinology and Metabolism: Jpem 15(Suppl 2): 737-744
Arslanian, S.A. 2000: Type 2 diabetes mellitus in children: pathophysiology and risk factors. Journal of Pediatric Endocrinology and Metabolism: Jpem 13(Suppl 6): 1385-1394
Papoz, L. 2002: Type 2 diabetes mellitus in the French overseas departments and territories: the "syndrome of Nauru". Diabetes and Metabolism 28(6 Pt 1): 505-507
Stewart, R.; Liolitsa, D. 1999: Type 2 diabetes mellitus, cognitive impairment and dementia. Diabetic Medicine: a Journal of the British Diabetic Association 16(2): 93-112
Husseini, A.; Abdul-Rahim, H.; Awartani, F.; Giacaman, R.; Jervell, J.; Bjertness, E. 2000: Type 2 diabetes mellitus, impaired glucose tolerance and associated factors in a rural Palestinian village. Diabetic Medicine: a Journal of the British Diabetic Association 17(10): 746-748
Halimi, S. 2001: Type 2 diabetes mellitus: which place for thiazolidinediones in the therapeutic strategy?. Diabetes and Metabolism 27(2 Part 2): 287-293
McElduff, A. 2001: Type 2 diabetes mellitus: an evolving therapeutic approach. Papua and new Guinea Medical Journal 44(3-4): 124-130
Fagan, T.C.; Sowers, J. 1999: Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy. Archives of Internal Medicine 159(10): 1033-1034
Mata Cases, M.; Cos Claramunt, X.; Bobé Molina, I.; Pujol Ribera, E.; Royo Pastor, C.; Centelles Fernández, R.; Davins Miralles, J.; Ferrer-Vidal Cortella, D.; Ortiz López, R. 2000: Type 2 diabetes mellitus: incidence and diagnosis at a primary care center. Atencion Primaria 25(7): 469-474
Ratner, R.E. 1998: Type 2 diabetes mellitus: the grand overview. Diabetic Medicine: a Journal of the British Diabetic Association 15(Suppl 4): S4-S7
Costa, B. 2002: Type 2 diabetes prevention: education, or medication too?. Medicina Clinica 119(16): 613-615
Osawa, H.; Onuma, H.; Makino, H. 2001: Type 2 diabetes susceptibility genes. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 46(16 Suppl): 2332-2336
Zangeneh, F.; Basu, A. 2002: Type 2 diabetes therapy and liver damage: the debate continues. Postgraduate Medicine 112(3): 23; Author Reply 23-4 82
Mayerson, A.B.; Inzucchi, S.E. 2002: Type 2 diabetes therapy. a pathophysiologically based approach. Postgraduate Medicine 111(3): 83
Florkowski, C.M.; Scott, R.S. 1999: Type 2 diabetes towards the new millennium--the relative importance of glycaemic versus lipid control. Australian and New Zealand Journal of Medicine 29(2): 249-253
Bo, S.; Repetti, E.; Pagano, G.; Cavello-Perin, P.; Gentile, L. 2002: Type 2 diabetes with onset in the elderly is not a benign disease. Diabetic Medicine: a Journal of the British Diabetic Association 19(9): 792-794
Thompson, C.F. 1999: Type 2 diabetes, nephropathy and HLA. New Zealand Medical Journal 112(1081): 41
Price, D.A.; Lansang, M.C.; Osei, S.Y.; Fisher, N.D.L.; Laffel, L.M.B.; Hollenberg, N.K. 2002: Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan. Diabetic Medicine: a Journal of the British Diabetic Association 19(10): 858-861
Lindsay, R.S.; Bennett, P.H. 2001: Type 2 diabetes, the thrifty phenotype - an overview. British Medical Bulletin 60: 21-32
Pedersen, O.B. 1999: Type 2 diabetes--and the role of therapeutic defeatism. Ugeskrift for Laeger 161(30): 4265
Chao-Pin, L.; Guy, Y.; Seung Joon, O. 2002: Type 2 diabetes--delivery approaches for novel therapeutics. Advanced Drug Delivery Reviews 54(9): 1161-1163
Grill, V.; Björklund, A. 2002: Type 2 diabetes--effect of compensatory oversecretion as a reason for beta-cell collapse. International Journal of Experimental Diabetes Research 3(3): 153-158
Lervang, H.H. 2001: Type 2 diabetes--new treatment. Ugeskrift for Laeger 163(44): 6101
Birkeland, K.I.; Berg, J.P. 2001: Type 2 diabetes--preventable, but how?. European Journal of Endocrinology 145(5): 573-575
Böhm, S. 1999: Type 2 diabetes. a new kind of insulin sensitizer at the door. MMW Fortschritte der Medizin 141(27): 56-57
Anonymous 2001: Type 2 diabetes. Acarbose interrupts the vicious circle. MMW Fortschritte der Medizin 143(14): 46-47
Drexler, A.J.; Robertson, C. 2001: Type 2 diabetes. how new insights, new drugs are changing clinical practice. Geriatrics 56(6): 20-24; 32-33
Struebing, P. 2000: Type 2 diabetes. Thoughts about an epidemic and your role in battling it. Jaapa: Official Journal of the American Academy of Physician Assistants 13(4): 108-112
Sica, D.A.; Bakris, G.L. 2002: Type 2 diabetes: RENAAL and IDNT--the emergence of new treatment options. Journal of Clinical Hypertension 4(1): 52-57
Daubresse, J.C. 2001: Type 2 diabetes: a refractory pathology?. Revue Medicale de Bruxelles 22(3): A184-A186
Spinas, G.A. 2002: Type 2 diabetes: an equivalent of coronary heart disease. Therapeutische Umschau. Revue Therapeutique 59(8): 379
Butler, R.N.; Rubenstein, A.H.; Gracia, A.M.; Zweig, S.C. 1998: Type 2 diabetes: causes, complications, and new screening recommendations. i. Geriatrics 53(3): 47-50; 53-54
Quinn, L. 2001: Type 2 diabetes: epidemiology, pathophysiology, and diagnosis. Nursing Clinics of North America 36(2): 175-192 V
Lardinois, C.K. 1998: Type 2 diabetes: glycemic targets and oral therapies for older patients. Geriatrics 53(11): 22-23; 27-8; 33-34 Passim
Brown, J.B.; Nichols, G.A.; Glauber, H.S.; Bakst, A.W. 1999: Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care 22(7): 1116-1124
Goldfine, A.B. 2001: Type 2 diabetes: new drugs, new perspectives. Hospital Practice 36(9): 29-36
Bouhanick, B.; Berrut, G.; Fressinaud, P.; Marre, M. 1998: Type 2 diabetes: new therapeutic perspectives. Presse Medicale 27(39): 2015-2024
Butler, R.N.; Rubenstein, A.H.; Gracia, A.M.; Zweig, S.C. 1998: Type 2 diabetes: patient education and home blood glucose monitoring. 3. Geriatrics 53(5): 60; 63-67
Russell, J.C. 2001: Type 2 diabetes: pharmacological intervention in an animal model. Advances in Experimental Medicine and Biology 498: 295-302
McFarland, K.F. 1997: Type 2 diabetes: stepped-care approach to patient management. Geriatrics 52(10): 22-26; 35, 39
Butler, R.N.; Rubenstein, A.H.; Gracia, A.M.; Zweig, S.C. 1998: Type 2 diabetes: treatment goals and pharmaceutical therapies. 2. Geriatrics 53(4): 42-48; 51
Grimaldi, A.; Hartemann-Heurtier, A. 2001: Type 2 diabetes: what therapeutic strategy?. Presse Medicale 30(6): 288-297
Anonymous 2000: Type 2 diabetic patients. Aggressive management of increased blood lipids. MMW Fortschritte der Medizin 142(20): 64
Modigliani, E. 1998: Type 2 endocrine neoplasms. Clinical aspects. Presse Medicale 27(13): 628-632
Modigliani, E. 1998: Type 2 endocrine neoplasms. Genetic aspects and diagnosis. Presse Medicale 27(13): 633-637
Modigliani, E. 1998: Type 2 endocrine neoplasms. Introduction. Presse Medicale 27(13): 627
Modigliani, E. 1998: Type 2 endocrine neoplasms. Prognosis and therapeutic problems. Presse Medicale 27(13): 638-640
Goldberg, J.A.; Bruce, W.J.; Sonnabend, D.H.; Walsh, W.R. 1997: Type 2 fractures of the distal clavicle: a new surgical technique. Journal of Shoulder and Elbow Surgery 6(4): 380-382
Onodera, K.; Hancock, W.W.; Graser, E.; Lehmann, M.; Sayegh, M.H.; Strom, T.B.; Volk, H.D.; Kupiec-Weglinski, J.W. 1997: Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients. Journal of Immunology 158(4): 1572-1581
Armengol, P.; Villena, M.J.; Caballero, E.; Juste, C. 1995: Type 2 human immunodeficiency virus infection in a female prostitute. Medicina Clinica 104(4): 156-157
Duysinx, B.; Scheen, A.J.; Paquot, N.; Daubresse, C.; Castillo, M.; Lefèbvre, P.J. 1994: Type 2 insulin-dependent diabetes: patient characteristics and effects of insulin therapy. Revue Medicale de Liege 49(6): 305-323
Sparks, S.M.; Vargas, J.D.; Shea, K.J. 2000: Type 2 intramolecular nitroso Diels-Alder reaction. Synthesis and structure of bridgehead oxazinolactams. Organic Letters 2(10): 1473-1475
Pachucki, J.; Hopkins, J.; Peeters, R.; Tu, H.; Carvalho, S.D.; Kaulbach, H.; Abel, E.D.; Wondisford, F.E.; Ingwall, J.S.; Larsen, P.R. 2001: Type 2 iodothyronin deiodinase transgene expression in the mouse heart causes cardiac-specific thyrotoxicosis. Endocrinology 142(1): 13-20
Imai, Y.; Toyoda, N.; Maeda, A.; Kadobayashi, T.; Fangzheng, G.; Nishikawa, M.; Iwasaka, T. 2001: Type 2 iodothyronine deiodinase expression is upregulated by the protein kinase A-dependent pathway and is downregulated by the protein kinase C-dependent pathway in cultured human thyroid cells. Thyroid: Official Journal of the American Thyroid Association 11(10): 899-907
Chen, W.M.; Hsieh, H.M.; Huang, P.C. 1998: Type 2 rice metallothionein-like gene has two introns. Dna Sequence: the Journal of Dna Sequencing and Mapping 8(4): 223-228
Happle, R.; Itin, P.H.; Brun, A.M. 1999: Type 2 segmental Darier disease. European Journal of Dermatology: Ejd 9(6): 449-451
König, A.; Happle, R. 2002: Type 2 segmental cutaneous leiomyomatosis. Acta Dermato-Venereologica 81(5): 383
König, A.; Hörster, S.; Vakilzadeh, F.; Happle, R. 2000: Type 2 segmental manifestation of Hailey-Hailey disease: poor therapeutic response to dermabrasion is due to severe involvement of adnexal structures. European Journal of Dermatology: Ejd 10(4): 265-268
Murata, Y.; Kumano, K.; Takai, T. 2001: Type 2 segmental manifestation of disseminated superficial porokeratosis showing a systematized pattern of involvement and pronounced cancer proneness. European Journal of Dermatology: Ejd 11(3): 191-194
Paneque, H.M.; Santos, F.N.; Tamayo, C.H.; Reynaldo, A.R.; Velázquez Pérez, L.; Almaguer Mederos, L.; Hechavarría, R.; Mouriño, F.T.; Cruz, M.T. 2001: Type 2 spinocerebellar ataxia: acceptance of prenatal diagnosis in descendents at risk. Revista de Neurologia 33(10): 904-908
Paneque, H.M.; Reynaldo, A.R.; Velázquez Pérez, L.; Santos, F.N.; Miranda, H.E.; Real, P.N.; García, E.R.; Hechavarría, P.R. 2001: Type 2 spinocerebellar ataxia: an experience in psychological rehabilitation. Revista de Neurologia 33(11): 1001-1005
Frattini, A.; Zucchi, I.; Villa, A.; Patrosso, C.; Repetto, M.; Susani, L.; Strina, D.; Redolfi, E.; Vezzoni, P.; Romano, G. 1993: Type 2 vasopressin receptor gene, the gene responsible nephrogenic diabetes insipidus, maps to Xq28 close to the LICAM gene. Biochemical and Biophysical Research Communications 193(3): 864-871
Meyer, D.; Fressinaud, E.; Hilbert, L.; Ribba, A.S.; Lavergne, J.M.; Mazurier, C. 2001: Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function. Best Practice and Research. Clinical Haematology 14(2): 349-364
Hanssen, K.F.; Birkeland, K.I.; Thorsby, P. 1998: Type 2-diabetes consists of several diseases. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(7): 1025
Brändle, M.; Schlaeppi, M.; Schmid, C. 2000: Type 2A multiple endocrine neoplasia with cutaneous lichen amyloidosis. Schweizerische Medizinische Wochenschrift 130(22): 861
Mathew, P.; Greist, A.; Maahs, J.A.; Lichtenberg, E.C.; Shapiro, A.D. 2003: Type 2B vWD: the varied clinical manifestations in two kindreds. Haemophilia: the Official Journal of the World Federation of Hemophilia 9(1): 137-144
Casonato, A.; Gaucher, C.; Pontara, E.; Zucchetto, A.; Zerbinati, P.; Mazurier, C.; Girolami, A. 1998: Type 2N von Willebrand disease due to Arg91Gln substitution and a cytosine deletion in exon 18 of the von Willebrand factor gene. British Journal of Haematology 103(1): 39-41
Mazurier, C.; Goudemand, J.; Hilbert, L.; Caron, C.; Fressinaud, E.; Meyer, D. 2001: Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology. Best Practice and Research. Clinical Haematology 14(2): 337-347
Bowen, D.J.; Standen, G.R.; Mazurier, C.; Gaucher, C.; Cumming, A.; Keeney, S.; Bidwell, J. 1998: Type 2N von Willebrand disease: rapid genetic diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F)--detection of a novel candidate type 2N mutation: C2810T (R854W). Thrombosis and Haemostasis 80(1): 32-36
McPherson, K. 1999: Type 3 errors, pill scares, and the epidemiology of oral contraception and health. Journal of Epidemiology and Community Health 53(5): 258-260
Arrecubieta, C.; López, R.; García, E. 1996: Type 3-specific synthase of Streptococcus pneumoniae (Cap3B) directs type 3 polysaccharide biosynthesis in Escherichia coli and in pneumococcal strains of different serotypes. Journal of Experimental Medicine 184(2): 449-455
Bruno, C.M.; Neri, S.; D'Angelo, G.; D'Amico, R.; Raciti, C.; Urso, G. 1997: Type 4 renal tubular acidosis caused by spironolactone. A case report. Minerva Medica 88(3): 93-95
Hussain, M.; Riordan, C.; Cronin, K. 2002: Type 5 avulsion of the insertion of the flexor digitorium profundus tendon. Journal of Hand Surgery 27(3): 296; Author Reply 296
Al-Qattan, M.M. 2001: Type 5 avulsion of the insertion of the flexor digitorum profundus tendon. Journal of Hand Surgery 26(5): 427-431
Sempere, A.P.; Millán, J.M.; Royo-Vilanova, C.; Medrano, V. 2001: Type 8 spinocerebellar ataxia. A report of a family. Revista de Neurologia 33(2): 150-152
Raddadi, A.A.; Al Twaim, A.A. 2000: Type a Niemann-Pick disease. Journal of the European Academy of Dermatology and Venereology: Jeadv 14(4): 301-303
Levran, O.; Desnick, R.J.; Schuchman, E.H. 1993: Type a Niemann-Pick disease: a frameshift mutation in the acid sphingomyelinase gene (fsP330) occurs in Ashkenazi Jewish patients. Human Mutation 2(4): 317-319
Suzuki, S.; Kondo, H.; Imoto, K.; Tobe, M.; Mo, M.; Iwai, Y.; Uchida, K.; Isoda, S.; Yano, Y.; Okamoto, M.; Nakamura, M.; Mori, T. 1998: Type A acute aortic dissection: late reoperations for dilatation of the distal false lumen and aortic regurgitation. Kyobu Geka. Japanese Journal of Thoracic Surgery 51(8 Suppl): 656-660
Higaki, K.; Ohno, K. 2001: Type a and B Niemann-Pick disease. Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 3): 305-308
Ad, N.; Lee, P.; Cox, J.L. 2002: Type A aortic dissection with associated anomaly of the carotid and vertebral vessels. Journal of Thoracic and Cardiovascular Surgery 123(3): 570-571
Szpakowski, E.; Biederman, A. 2001: Type A aortic dissection. General considerations and results of 173 operations. Acta Chirurgica Belgica 101(4): 173-178
De Paulis, R.; Colella, D.F.; Bassano, C.; Ricci, A.; Chiariello, L. 1994: Type A aortic dissection: management of brain malperfusion through retrograde cerebral perfusion. Journal of Thoracic and Cardiovascular Surgery 108(4): 788-789
Fujii, T.; Kida, M. 1999: Type A behavior and cognitive processings reflected in event-related brain potentials to concurrent tasks. Shinrigaku Kenkyu: Japanese Journal of Psychology 70(4): 293-300
Cheour, M.; Kallalou, K.; Haffani, F. 1998: Type A behavior and coronary disease: update. La Tunisie Medicale 76(5): 107-112
Eason, K.E.; Mâsse, L.C.; Tortolero, S.R.; Kelder, S.H. 2002: Type a behavior and daily living activity among older minority women. Journal of Women's Health and Gender-Based Medicine 11(2): 137-146
Ravaja, N.; Keltikangas-Järvinen, L.; Viikari, J. 1996: Type a behavior and metabolic syndrome precursors in young adults. Journal of Clinical Epidemiology 49(3): 335-343
Ramanaiah, N.V.; Sharpe, J.P.; Byravan, A. 1997: Type a behavior and the five-factor model of personality. Psychological Reports 81(2): 368-370
Karlberg, L.; Krakau, I.; Undén, A.L. 1998: Type A behavior intervention in primary health care reduces hostility and time pressure: a study in Sweden. Social Science and Medicine 46(3): 397-402
Schaubroeck, J.; Williams, S. 1993: Type a behavior pattern and escalating commitment. Journal of Applied Psychology 78(5): 862-867
Maeda, S. 1994: Type a behavior pattern as a risk factor for coronary heart disease. Nihon Rinsho. Japanese Journal of Clinical Medicine 52 Suppl (Part 2): 53-58
Reynoso Erazo, L.; Seligson, I. 1997: Type a behavior pattern in Mexico: use of a new evaluation tool. Archivos del Instituto de Cardiologia de Mexico 67(5): 419-427
Buller, J.C.; Kritz-Silverstein, D.; Barrett-Connor, E.; Wingard, D. 1998: Type a behavior pattern, heart disease risk factors, and estrogen replacement therapy in postmenopausal women: the Rancho Bernardo Study. Journal of Women's Health 7(1): 49-56
Lynch, D.J.; Schaffer, K.F.; Hinojosa, L. 2000: Type a behavior pattern, sex, and social support. Psychological Reports 87(1): 141-147
Etienne, A.M.; Fontaine, O. 1994: Type a behavior pattern, stress and coronary disease. II. Practical aspects. Revue Medicale de Liege 49(1): 36-48
Sanders, G.S.; Malkis, F.S. 1982: Type A behavior, need for control, and reactions to group participation. Organizational Behavior and Human Performance 30(1): 71-86
Sumi, K.; Kanda, K. 2001: Type A behavior, social support, and sex in Japanese college students. Psychological Reports 88(3 Pt 1): 797-798
Sumi, K. 1998: Type a behavior, social support, stress, and physical and psychological well-being among Japanese women. Psychological Reports 83(2): 711-717
Fernández-Concepción, O.; Verdecie-Feria, O.; Chávez-Rodríguez, L.; Alvarez-González, M.A.; Fiallo-Sánchez, M.C. 2002: Type A behaviour and life events as risk factors for cerebral infarct. Revista de Neurologia 34(7): 622-627
Von Lindern, J.J.; Niederhagen, B.; Appel, T.; Bergé, S.; Reich, R.H. 2001: Type a botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment. Plastic and Reconstructive Surgery 107(2): 327-332
Von Lindern, J.J. 2001: Type a botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction. Acta Neurologica Belgica 101(1): 39-41
Kreyden, O.P.; Böni, R.; Burg, G. 2000: Type A botulinum toxin: a new methods in treating focal hyperhidrosis. A summary of various possibilities in hyperhidrosis therapy with special emphasis type A botulinum toxin injections. Praxis 89(21): 909-915
Sutton, A.G.; Aggarwal, R.K.; de Belder, M.A. 2000: Type A dissection of the ascending thoracic aorta during percutaneous coronary intervention. Journal of Invasive Cardiology 12(3): 147-150
Ravaja, N.; Keltikangas-Järvinen, L.; Keskivaara, P. 1996: Type a factors as predictors of changes in the metabolic syndrome precursors in adolescents and young adults--a 3-year follow-up study. Health Psychology: Official Journal of the Division of Health Psychology American Psychological Association 15(1): 18-29
Shahryar, S.; Carlson, R.W. 2000: Type a lactic acidosis in cardiogenic shock. Critical Care Medicine 28(12): 3932
Tchénio, X.; Bertocchi, M.; McGrégor, B.; Daoud, S.; Mornex, J.F.; Cordier, J.F. 1996: Type AA renal amyloidosis in sarcoidosis. Revue des Maladies Respiratoires 13(6): 601-602
Tanasescu, S.; Joly, P.; Le Corvaisier-Pieto, C.; Rzeznik, J.C.; Lauret, P. 1996: Type B Haemophilus influenzae cellulitis in an immunocompetent adult. Annales de Dermatologie et de Venereologie 123(12): 827-828
Nahas, K.; Hanton, G.; Rabemampianina, Y.; Sacre-Salem, B. 1998: Type B Ventricular Preexcitation With Abnormal Contraction of the Ventricular Septum in a Dog. Contemporary Topics in Laboratory Animal Science 37(5): 78-81
Gaeta, G.B.; Stornaiuolo, G.; Precone, D.F. 2001: Type B and D viral hepatitis: epidemiological changes in Southern Europe. Forum 11(2): 126-133
Velissaris, T.J.; Lloyd, C.T.; Ohri, S.K. 2002: Type B aortic dissection and right hemothorax. Asian Cardiovascular and Thoracic Annals 10(2): 197
Bloch, M.J.; Trost, D.W.; Sos, T.A. 2001: Type B aortic dissection complicating renal artery angioplasty and stent placement. Journal of Vascular and Interventional Radiology: Jvir 12(4): 517-520
Singh, R.S.; Danikas, D.; Goldenkranz, R. 2002: Type B aortic dissection with rupture of the left common iliac artery: a case report. American Surgeon 68(1): 49-51
Lamboley, G.; Mandel, R.; Müller, S.; Douard, P.; Métral, S.; Durand, P. 2001: Type B botulism: a family outbreak. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 8(3): 286-289
Senthil, V.; Treasure, T. 1996: Type B dissection involving a right-sided aortic arch. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 10(6): 477-479
Fonga-Djimi, H.; Gottrand, F.; Mazingue, F.; Farriaux, J.P. 1993: Type B hepatitis and primary hepatocellular carcinoma in a nine-year-old French boy. Acta Paediatrica 82(12): 1065
Aggarwal, A.; al-Talib, K.; Alabrash, M. 1996: Type B lactic acidosis in an AIDS patient treated with zidovudine. Maryland Medical Journal 45(11): 929-931
Vasseur, B.G.; Kawanishi, H.; Shah, N.; Anderson, M.L. 2002: Type B lactic acidosis: a rare complication of antiretroviral therapy after cardiac surgery. Annals of Thoracic Surgery 74(4): 1251-1252
Yamada, G. 2001: Type B liver cirrhosis. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 90(1): 50-55
Marcozzi, G.; Befani, O.; Mondovì, B. 1998: Type B monoamine oxidase activity in human brain malignant tumors. Cancer Biochemistry Biophysics 16(3): 287-294
Castro, A.; Dias, P.; Pereira, M.; Pimenta, J.; Friões, F.; Rodrigues, R.; Ferreira, A.; Bettencourt, P. 2001: Type B natriuretic peptide in the diagnosis of heart failure with preserved systolic function. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 20(11): 1109-1113
Carrillo-Esper, R.; Cruz-Bautista, I.; Guizar-Flores, S. 2001: Type B right ventricle thrombus in transit. Gaceta Medica de Mexico 137(4): 355-356
Li, Y.; Wang, S.; Xia, Y. 1995: Type B supersonic diagnostic observation on the action of 25 kinds of traditional Chinese medicine on gallbladder movement. Zhongguo Zhong Yao Za Zhi 20(12): 754
Kuwamura, M.; Awakura, T.; Shimada, A.; Umemura, T.; Kagota, K.; Kawamura, N.; Naiki, M. 1993: Type C Niemann-Pick disease in a boxer dog. Acta Neuropathologica 85(3): 345-348
Tohyama, J.; Kato, M.; Koeda, T.; Ohno, K. 1993: Type C Niemann-Pick disease. Detection and quantification of cholesterol-accumulating cells in bone marrow. Brain and Development 15(4): 316-317
Wobeser, G.; Baptiste, K.; Clark, E.G.; Deyo, A.W. 1997: Type C botulism in cattle in association with a botulism die-off in waterfowl in Saskatchewan. Canadian Veterinary Journal 38(12): 782
Van der Lugt, J.J.; Henton, M.M.; Steyn, B.G. 1996: Type C botulism in sheep associated with the feeding of poultry litter. Journal of the South African Veterinary Association 67(1): 3-4
Hashimoto, N.; Makino, H. 1994: Type C insulin resistance. Nihon Rinsho. Japanese Journal of Clinical Medicine 52(10): 2637-2640
Yokosuka, O. 2001: Type C liver cirrhosis. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 90(1): 56-62
Del Canho, H.; van den Bergh, F.A.; Duran, M.; Hennekam, R.C.; Gröniger, A.M.; Poorthuis, B.J. 1993: Type D Sanfilippo disease in an 8-year-old boy; a rare cause of mental retardation. Nederlands Tijdschrift Voor Geneeskunde 137(19): 969-972
Hasuo, K.; Mizushima, A.; Matsumoto, S.; Uchino, A.; Uehara, S.; Miyoshi, M.; Mihara, F.; Ohmagari, J.; Ohnishi, Y.; Masuda, K. 1996: Type D dural carotid-cavernous fistula. Results of combined treatment with irradiation and particulate embolization. Acta Radiologica 37(3 Part 1): 294-298
Morozov, V.A.; Lagaye, S.; Lyakh, L.; ter Meulen, J. 1996: Type D retrovirus markers in healthy Africans from Guinea. Research in Virology 147(6): 341-351
Pradere, B.; Bloom, E.; Labbé, F.; Seulin, P.; Gouzi, J.L. 1999: Type D2 and "D 1.5" lymphadenectomy techniques in surgery of stomach cancer. Annales de Chirurgie 53(9): 915-919
Fanger, N.A.; Wardwell, K.; Shen, L.; Tedder, T.F.; Guyre, P.M. 1996: Type i (CD64) and type Ii (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. Journal of Immunology 157(2): 541-548
Wicklein, E.M.; Pfeiffer, G.; Ratusinski, T.; Kunze, K. 1997: Type i Charcot-Marie-Tooth syndrome. Disability and management. Der Nervenarzt 68(4): 358-362
Benito González, J.; Beltrán Mateos, L.; Benito González, F.; Pérez Plasencia, D.; Santa Cruz Ruiz, S.; Figueroa García, T. 2000: Type i Chiari malformation as a cause of inferior vertical nystagmus. Anales Otorrinolaringologicos Ibero-Americanos 27(5): 501-508
Wysokiński, T.; Kiwic, G. 1998: Type i Chiari malformation coexisting with syringomyelia: pathogenesis, treatment choice and prognostic factors for remote outcome in the light of own case. Neurologia i Neurochirurgia Polska 32(6): 1571-1582
Moro, E.R.; Teive, H.A.; de Souza, S.M.; Lambrecht, F.; Werneck, L.C. 1999: Type I Chiari malformation: report of 2 cases with unusual clinical presentation. Arquivos de Neuro-Psiquiatria 57(3a): 666-671
Lacour, J.P. 1998: Type i Ehlers-Danlos syndrome. Annales de Dermatologie et de Venereologie 125(12): 926
Martínez Odriozola, P.; Ferrero Benéitez, O.L.; Miguel de la Villa, F. 1997: Type I Gaucher's disease. Report of 2 affected families. Revista Clinica Espanola 197(3): 172-175
Durbin, J.E.; Fernandez-Sesma, A.; Lee, C.K.; Rao, T.D.; Frey, A.B.; Moran, T.M.; Vukmanovic, S.; García-Sastre, A.; Levy, D.E. 2000: Type i IFN modulates innate and specific antiviral immunity. Journal of Immunology 164(8): 4220-4228
Hino, K.; Yamaguchi, Y.; Okita, K. 2001: Type i IFN receptor. Nihon Rinsho. Japanese Journal of Clinical Medicine 59(7): 1351-1355
Deshpande, S.; O'Doherty, D. 2001: Type i Monteggia fracture dislocation associated with ipsilateral distal radial epiphyseal injury. Journal of Orthopaedic Trauma 15(5): 373-375
Ninomiya, M.; Makuuchi, H.; Naruse, Y.; Kobayashi, T.; Sato, T. 1999: Type I acute aortic dissection accompanied by ischemic enterocolitis due to blood flow insufficiency in the superior mesenteric artery. Japanese Journal of Thoracic and Cardiovascular Surgery: Official Publication of the Japanese Association for Thoracic Surgery 47(9): 465-469
Heese, A.; Peters, K.P.; Koch, H.U. 1997: Type i allergies to latex and the aeroallergenic problem. European Journal of Surgery. Supplement.: 579: 19-22
Swiatkowski, M.; Kłopocka, M.; Suppan, K. 1993: Type i allergy and indices of immune response in patients with ulcerative colitis. Wiadomosci Lekarskie 46(13-14): 496-501
Quiel, V. 1996: Type i allergy to latex after gynecologic examination. Zentralblatt für Gynakologie 118(4): 225-227
Santala, M.; Simojoki, M.; Risteli, J.; Risteli, L.; Kauppila, A. 1999: Type i and IIi collagen metabolites as predictors of clinical outcome in epithelial ovarian cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(12): 4091-4096
Treska, V.; Topolcan, O.; Kocová, J.; Pecen, L.; Tonar, Z. 1999: Type i and IIi procollagen in patients with abdominal aorta aneurysms. Casopis Lekaru Ceskych 138(5): 142-146
Solov'eva, N.I.; Vinokurova, S.V.; Dilakian, E.A.; Gureeva, T.A.; Zhurbitskaia, V.A.; Balaevskaia, T.O. 2001: Type i and IV collagenases and their endogenous regulators in immortalized and transformed fibroblasts. Voprosy Meditsinskoi Khimii 47(1): 72-79
Buysschaert, M. 1995: Type i and Type Ii diabetes: from genetics to clinical practice. Bulletin de la Societe Belge d'Ophtalmologie 256: 9-10
White, G.H.; May, J.; Waugh, R.C.; Yu, W. 1998: Type I and Type II endoleaks: a more useful classification for reporting results of endoluminal AAA repair. Journal of Endovascular Surgery: the Official Journal of the International Society for Endovascular Surgery 5(2): 189-191
Sivridis, E..; Buckley, C..H..; Fox, H.. 1993: Type i and Type Ii estrogen and progesterone binding sites in endometrial carcinomas: their value in predicting survival. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 3(2): 80-88
Alves, M.F.; Filgueira, A.L.; Lorena, D.E.; Porto, L.C. 1998: Type i and type IIi collagens in cutaneous mucinosis. American Journal of Dermatopathology 20(1): 41-47
Fu, Q.; Xu, X.; Ding, Q.; Hu, Y.; Wang, X.; Wang, H. 2002: Type i antithrombin deficiency due to 13389G deletion in antithrombin gene. Zhonghua Xue Ye Xue Za Zhi 23(11): 588-590
Ashraf, S.S.; Shaukat, N.; Masood, M.; Lyons, T.J.; Keenan, D.J. 1993: Type I aortic dissection in a patient with osteogenesis imperfecta. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 7(12): 665-666
Scanavacca, M.; Sosa, E.; Velarde, J.L.; D'Avila, A.; Hachul, D.; Reolão, B.; Sanches, O.; Silva, M.; Darrieux, F. 1998: Type i atrial flutter radiofrequency ablation. Importance of bidirectional block of isthmus between the inferior vena cava and of tricuspid valve ring. Arquivos Brasileiros de Cardiologia 71(5): 705-711
Houghton; Aers; Yang; Wang; Rowell 1995: Type i band alignment in Si1-xGex/Si(001) quantum wells: photoluminescence under applied. Physical Review Letters 75(5): 866-869
Tejedor-Junco, M.T.; González-Martín, M.; Lupiola, P.; González-Lama, Z. 1998: Type i beta-lactamases of Enterobacter cloacae and resistance to beta-lactam antibiotics. Folia Microbiologica 43(6): 683-686
Behrns, K.E.; Shaheen, N.J.; Grimm, I.S. 1998: Type I choledochal cyst in association with familial adenomatous polyposis. American Journal of Gastroenterology 93(8): 1377-1379
Talonpoika, J.T.; Hämäläinen, M.M. 1994: Type i collagen carboxyterminal telopeptide in human gingival crevicular fluid in different clinical conditions and after periodontal treatment. Journal of Clinical Periodontology 21(5): 320-326
Ziober, B.L.; Turner, M.A.; Palefsky, J.M.; Banda, M.J.; Kramer, R.H. 2000: Type i collagen degradation by invasive oral squamous cell carcinoma. Oral Oncology 36(4): 365-372
Baslé, M.F.; Lesourd, M.; Grizon, F.; Pascaretti, C.; Chappard, D. 1998: Type i collagen in xenogenic bone material regulates attachment and spreading of osteoblasts over the beta1 integrin subunit. Der Orthopade 27(2): 136-142
Gray, Y.; Bruno, N.; Badiavas, E.V.; Wilkel, C.S. 2002: Type i cryoglobulinemia presenting as hemorrhagic crusted leg ulcers. Cutis 70(6): 319-323
Hirsch, I.B.; Farkas-Hirsch, R. 1993: Type i diabetes and insulin therapy. Nursing Clinics of North America 28(1): 9-23
Grimm, J.J.; Muchnick, S. 1993: Type i diabetes and marathon running. Diabetes Care 16(12): 1624
Kotanko, P. 1997: Type i diabetes and the "milk hypothesis". Diabetes Care 20(2): 233-234
Sebastiani, L.; Adorisio, E.; Visalli, N.; Conte, A.; D'Elia, R.; Pozzilli, P. 2001: Type I diabetes in Lazio. Note 1: incidence in 1989-1998. Annali di igiene: medicina preventiva e di comunita 13(5): 393-398
Herwig, J. 1997: Type i diabetes mellitus in childhood and adolescence. Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 91(3): 233-242
Goday, A.; Castell, C.; Lloveras, G. 1993: Type i diabetes mellitus registries. a current necessity. Medicina Clinica 101(11): 431-436
Anhalt, H.; Eckert, K.H.; Hintz, R.L.; Neely, E.K. 1996: Type i diabetes mellitus, ketoacidosis and thromboembolism in an adolescent with Prader-Willi syndrome. Acta Paediatrica 85(4): 516
Ryff, A.S.; Berger, W.; Crausaz, F. 1994: Type i diabetes mellitus: insulin treatment. Schweizerische Medizinische Wochenschrift. Supplementum 60: 7-13
Godambe, S.V.; Sharief, N. 1999: Type i diabetes, also known as insulin dependent diabetes mellitus or juvenile diabetes, is one of the disorders with a complex genetic basis. Early Human Development 54(3): 295-296
Datiles, M.B.; Kador, P.F. 1999: Type i diabetic cataract. Archives of Ophthalmology 117(2): 284-285
Selgas, R.; Bajo, M.A.; Cirugeda, A.; Castro, M.J.; del Peso, G.; Aguilera, A.; Fernández-Perpén, A.; Sánchez-Tomero, J.A. 2000: Type i early failure of peritoneal ultrafiltration (UF). Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 20(Suppl 2): 41-45
Haulon, S.ép.; Willoteaux, S.; Koussa, M.; Halna, P.; Beregi, J.-P. 2002: Type i endoleaks: is aneurysm rupture risk dependent on the presence of type Ii endoleaks?. Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists 9(5): 707-709
Hsu, S.P.; Cheng, S.Y. 1993: Type I familial amyloid polyneuropathy--report of a family in Taiwan. Changgeng Yi Xue Za Zhi 16(3): 193-202
Arrieta, F.J.; Saavedra, P.; Alvarez, C.; Franco, P.; Hernández, G.; Varela, L. 1993: Type i familial pseudohypoparathyroidism: clinical and hormonal study. Revista Clinica Espanola 193(4): 172-175
Lagrew, D.C.; Morgan, M.A.; Branigan, T.; Lee, T.; Randall, R. 1994: Type I fetal cystic adenomatoid malformation of the lung with hydrops at 18 weeks' gestation: a case report. Journal of Perinatology: Official Journal of the California Perinatal Association 14(4): 316-318
Demir, Y.; Cenetoğlu, S.; Akyürek, N.; Yavuzer, R. 2001: Type i first branchial cleft anomaly resembling an epidermal cyst. Annals of Plastic Surgery 46(3): 350-351
Jordan, P.H. 1996: Type i gastric ulcer treated by parietal cell vagotomy and mucosal ulcerectomy. Journal of the American College of Surgeons 182(5): 388-393
Poll, L.W.; Koch, J.A.; vom Dahl, S.; Sarbia, M.; Niederau, C.; Häussinger, D.; Mödder, U. 2000: Type i gaucher disease: extraosseous extension of skeletal disease. Skeletal Radiology 29(1): 15-21
Artigas, J.; Ribes, A.; Rovira, A.; Lorente, I.; Briones, M.P. 1995: Type i glutaric acidity with arachnoidal cysts. Revista de Neurologia 23(119): 153-156
Prats Viñas, J.M.; Garaizar Axpe, C. 1997: Type I glutaric aciduria. Neurologia 12(9): 404
Yüce, A.; Coşkun, T.; Koçak, N.; Ozsoylu, S.; Ozalp, I.; Göğüş, S. 1993: Type I glycogenosis with renal tubular dysfunction (presentation of two cases). Turkish Journal of Pediatrics 35(3): 201-204
Gullick, W.J. 1998: Type i growth factor receptors: current status and future work. Biochemical Society Symposium 63: 193-198
Ishida, S.; Isotani, H.; Furukawa, K.; Kuhara, T. 2000: Type i homocystinuria associated with megaloblastic anemia. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 89(12): 2528-2530
Hoffmann, M.M.; Jacob, S.; Luft, D.; Schmülling, R.M.; Rett, K.; März, W.; Häring, H.U.; Matthaei, S. 2000: Type i hyperlipoproteinemia due to a novel loss of function mutation of lipoprotein lipase, Cys(239)-->Trp, associated with recurrent severe pancreatitis. Journal of Clinical Endocrinology and Metabolism 85(12): 4795-4798
Leprince, E.; André, C.; Descos, L. 1995: Type i hypersensitivity reactions and etiopathogenesis of hemorrhagic rectocolitis. Presse Medicale 24(39): 1902-1906
O'Malley, K.E.; Sloan, T.; Joyce, P.; Baird, A.W. 1993: Type i hypersensitivity reactions in intestinal mucosae from rats infected with Fasciola hepatica. Parasite Immunology 15(8): 449-453
Winter, W.E. 1996: Type i insulin-dependent diabetes mellitus: a model for autoimmune polygenic disorders. Advances in Dental Research 10(1): 81-87
Cull, V.S.; Tilbrook, P.A.; Bartlett, E.J.; Brekalo, N.L.; James, C.M. 2003: Type i interferon differential therapy for erythroleukemia: specificity of STAT activation. Blood 101(7): 2727-2735
Honda, Y.; Rogers, L.; Nakata, K.; Zhao, B.Y.; Pine, R.; Nakai, Y.; Kurosu, K.; Rom, W.N.; Weiden, M. 1998: Type i interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. Journal of Experimental Medicine 188(7): 1255-1265
De Maeyer, E.; De Maeyer-Guignard, J. 1998: Type I interferons. International Reviews of Immunology 17(1-4): 53-73
Williams, B.R.G. 2002: Type i interferons (IFN) are essential mediators of innate and specific immunity against viruses. Viral Immunology 15(1): 1-2
Lisak, R.P. 2000: Type i interferons and chronic inflammatory demyelinating polyneuropathy: treatment or cause?. Muscle and Nerve 23(3): 307-309
Nortvedt, M.W.; Riise, T.; Myhr, K.M.; Nyland, H.I.; Hanestad, B.R. 1999: Type i interferons and the quality of life of multiple sclerosis patients. Results from a clinical trial on interferon alfa-2a. Multiple Sclerosis 5(5): 317-322
Mizuguchi, J.; Takeuchi, M.; Usui, M. 2002: Type i interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis. Archivum Immunologiae et Therapiae Experimentalis 50(4): 243-254
Scheel-Toellner, D.; Akbar, A.N.; Pilling, D.; Orteu, C.H.; Buckley, C.D.; Wang, K.; Webb, P.R.; Lord, J.M.; Salmon, M. 2000: Type i interferons inhibit the resolution of chronic inflammation. Symposia of the Society for Experimental Biology 52: 277-288
Ermentrout, B. 1996: Type i membranes, phase resetting curves, and synchrony. Neural Computation 8(5): 979-1001
Andresdottir, M.B.; Assmann, K.J.; Hilbrands, L.B.; Wetzels, J.F. 2000: Type i membranoproliferative glomerulonephritis in a renal allograft: a recurrence induced by a cytomegalovirus infection?. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 35(2): E6
Chidambaram, M.; Stigant, C.E.; Sugar, L.M.; Ramesh Prasad, G.V. 2002: Type i membranoproliferative glomerulonephritis in an HIV-infected individual without hepatitis C co-infection. Clinical Nephrology 57(2): 154-157
Barcik, U.; Quijano-Roy, S.; Caballero-Martín, M.A.; Viaño, J.; Pascual-Castroviejo, I. 1999: Type i neurofibromatosis associated with internal carotid artery hypoplasia. Anales Espanoles de Pediatria 51(6): 687-689
Carod-Artal, F.J.; Melo, M.; da Silva, R.T.; Rizzo, I.; Vázquez, C.; Brenner, C. 2000: Type I neurofibromatosis presenting as a progressive cervical myelopathy. The first case reported in Kaxinawa Indians. Revista de Neurologia 31(4): 307-310
Danek, A.; Wahlländer-Danek, U.; Stenglein-Krapf, G.; Uttner, I. 2001: Type i neurofibromatosis. a model for the study of molecular principles of cognition. Der Nervenarzt 72(12): 963-967
Tzao, C.; Nickerson, P.A.; Steinhorn, R.H.; Noble, B.K.; Swartz, D.D.; Russell, J.A. 2002: Type i nitric oxide synthase is decreased in the fetal pulmonary circulation of hypertensive lambs. Pediatric Pulmonology 33(6): 437-442
Alvarez, J.; Iglesias, J.; Pulido, O.; Maldonado, L.; San Juan, G.; Sanchez, P.; Corral, E.; Medina, J.C. 1997: Type i non-heart-beating donors: policy and results. Transplantation Proceedings 29(8): 3552
Rawlings, B.J. 2001: Type i polyketide biosynthesis in bacteria (Part A--erythromycin biosynthesis). Natural Product Reports 18(2): 190-227
Rawlings, B.J. 2001: Type i polyketide biosynthesis in bacteria (part B). Natural Product Reports 18(3): 231-281
Parsons, D.S.; Stivers, F.E.; Giovanetto, D.R.; Phillips, S.E. 1998: Type I posterior laryngeal clefts. Laryngoscope 108(3): 403-410
Zheng, Y.; Zhu, D.; Zhou, B. 1998: Type i protein C deficiency caused by a novel protein C gene mutation. Zhonghua Xue Ye Xue Za Zhi 19(3): 138-142
Baselga, J.; Mendelsohn, J. 1997: Type i receptor tyrosine kinases as targets for therapy in breast cancer. Journal of Mammary Gland Biology and Neoplasia 2(2): 165-174
Christophe, J. 1993: Type i receptors for PACAP (a neuropeptide even more important than VIP?). Biochimica et Biophysica Acta 1154(2): 183-199
Webb, M.D. 1995: Type i second-degree AV block after neostigmine administration in a child with renal failure. Anesthesia Progress 42(1): 21-22
Rufo Campos, M.; Arias León, E.; Martínez López, A.; Chinchón Lara, I.; Gómez de Terreros, I. 1993: Type i spinal muscular atrophy in twins. Anales Espanoles de Pediatria 38(6): 557-558
Maragos, N.E. 1997: Type i thyroplasty: pitfalls of modifying the Isshiki approach. how i do it. Journal of Voice: Official Journal of the Voice Foundation 11(4): 470-473
Nakamura, K.; Patterson, R.M.; Moritomo, H.; Viegas, S.F. 2001: Type i versus type Ii lunates: Ligament anatomy and presence of arthrosis. Journal of Hand Surgery 26(3): 428-436
Choo-Kang, L.R.; Zeitlin, P.L. 2000: Type I, II, III, IV, and V cystic fibrosis transmembrane conductance regulator defects and opportunities for therapy. Current Opinion in Pulmonary Medicine 6(6): 521-529
Chung, K.C.; Kalliainen, L.K.; Hayward, R.A. 1998: Type II (beta) errors in the hand literature: the importance of power. Journal of Hand Surgery 23(1): 20-25
Bodzin, B.J. 1997: Type Ii (noninsulin-dependent) diabetes: new treatment options. Home Healthcare Nurse 15(1): 41-47
Takahashi, K.I.; Fukushima, K.; Sasano, H.; Sasaki, I.; Matsuno, S.; Krozowski, Z.S.; Nagura, H. 1999: Type Ii 11beta-hydroxysteroid dehydrogenase expression in human colonic epithelial cells of inflammatory bowel disease. Digestive Diseases and Sciences 44(12): 2516-2522
Lee, Y.S.; Poh, L.K.; Ida, H.; Loke, K.Y. 2001: Type Ii Gaucher disease: compound heterozygote with RecNcii and L444P mutations. Journal of Tropical Pediatrics 47(2): 115-117
Nakashima, H.; Kondo, K.; Saka, K. 2000: Type Ii Monteggia lesion with fracture-separation of the distal physis of the radius. American Journal of Orthopedics 29(9): 717-719
Markaverich, B.M.; Alejandro, M.A. 1998: Type Ii [3H]estradiol binding site antagonists: inhibition of normal and malignant prostate cell growth and proliferation. International Journal of Oncology 12(5): 1127-1135
Lustig, K.D.; Conklin, B.R.; Herzmark, P.; Taussig, R.; Bourne, H.R. 1993: Type Ii adenylylcyclase integrates coincident signals from Gs, Gi, and Gq. Journal of Biological Chemistry 268(19): 13900-13905
Sulkowski, S. 1998: Type Ii alveolar epithelial cells and cyclophosphamide-induced lung fibrosis. Roczniki Akademii Medycznej W Bialymstoku 43: 160-168
Sulkowska, M.; Sulkowski, S.; Dziecioł, J. 1996: Type Ii alveolar epithelial cells promote fibrosis during development of experimental lung emphysema. Folia Histochemica et Cytobiologica 34(Suppl 1): 27-28
Celeste, F.; Pepi, M. 1998: Type II aortic dissection complicating discrete subvalvular aortic stenosis in an adult man. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography 11(4): 399-402
Doni, F.; Staffiere, E.; Manfredi, M.; Piemonti, C.; Todd, S.; Rimondini, A.; Fiorentini, C. 1996: Type Ii atrial flutter interruption with transesophageal pacing: use of propafenone and possible change of the substrate. Pacing and Clinical Electrophysiology: Pace 19(11 Part 2): 1958-1961
Vergani, D.; Mieli-Vergani, G. 1993: Type Ii autoimmune hepatitis: the conundrum of cytochrome P450IID6. Clinical and Experimental Immunology 92(3): 367-368
Bénichou, O.D.; Laredo, J.D.; de Vernejoul, M.C. 2000: Type Ii autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients. Bone 26(1): 87-93
Diller, T.C.; Xuong, N.H.; Taylor, S.S. 2000: Type Ii beta regulatory subunit of cAMP-dependent protein kinase: purification strategies to optimize crystallization. Protein Expression and Purification 20(3): 357-364
Ohara, R.; Yamakawa, H.; Nakayama, M.; Ohara, O. 2000: Type II brain 4.1 (4.1B/KIAA0987), a member of the protein 4.1 family, is localized to neuronal paranodes. Brain Research. Molecular Brain Research 85(1-2): 41-52
Rannels, D.E. 1996: Type Ii cell differentiation in culture. American Journal of Physiology 270(4 Part 1): L483
Cowan, N.J.; Lewis, S.A. 2001: Type Ii chaperonins, prefoldin, and the tubulin-specific chaperones. Advances in Protein Chemistry 59: 73-104
Stoop, R.; Buma, P.; van der Kraan, P.M.; Hollander, A.P.; Billinghurst, R.C.; Meijers, T.H.; Poole, A.R.; van den Berg, W.B. 2001: Type II collagen degradation in articular cartilage fibrillation after anterior cruciate ligament transection in rats. Osteoarthritis and Cartilage 9(4): 308-315
Stoop, R.; van der Kraan, P.M.; Buma, P.; Hollander, A.P.; Billinghurst, R.C.; Poole, A.R.; van den Berg, W.B. 1999: Type II collagen degradation in spontaneous osteoarthritis in C57Bl/6 and BALB/c mice. Arthritis and Rheumatism 42(11): 2381-2389
Young, R.D.; Vaughan-Thomas, A.; Wardale, R.J.; Duance, V.C. 2002: Type Ii collagen deposition in cruciate ligament precedes osteoarthritis in the guinea pig knee. Osteoarthritis and Cartilage 10(5): 420-428
O'Driscoll, S.W.; Commisso, C.N.; Fitzsimmons, J.S. 1995: Type Ii collagen quantification in experimental chondrogenesis. Osteoarthritis and Cartilage 3(3): 197-203
Boissier, M.C.; Fournier, C. 1994: Type Ii collagen: from experimental arthritis to treatment of rheumatoid polyarthritis. Revue du Rhumatisme 61(3): 150-152
Sykora, K.W.; Niedich, J.; Price, J.; Bussel, J. 1994: Type Ii congenital dyserythropoietic anemia in a patient with ectodermal dysplasia. Distinction from dyskeratosis congenita. American Journal of Pediatric Hematology/Oncology 16(2): 173-176
Wingenfeld, P.; Minor, T.; Solbach, C.; Käsgen, U.; Muhl, B.; Göpel, E. 1993: Type Ii diabetes (NIDDM): overview of the preclinical and clinical status exemplified by the patient sample of a general hospital in a rural district. Medizinische Klinik 88(11): 629-636
Jones, J.W.; Mizrahi, S.S.; Bentley, F.R. 1996: Type Ii diabetes after combined kidney and pancreas transplantation for type i diabetes mellitus and end-stage renal disease. Clinical Transplantation 10(6 Part 1): 574-575
Peters, A.; Kerner, W. 1996: Type Ii diabetes and hypertension. Medizinische Klinik 91(10): 640-645
Hörnquist, J.O.; Wikby, A.; Stenström, U.; Andersson, P.O.; Akerlind, I. 1995: Type II diabetes and quality of life: a review of the literature. Pharmacoeconomics 8 Suppl. 1: 12-16
Kyriakides, Z.S.; Psychari, S.; Chrysomallis, N.; Georgiadis, M.; Sbarouni, E.; Kremastinos, D.T. 2002: Type II diabetes does not prevent the recruitment of collateral vessels and the normal reduction of myocardial ischaemia on repeated balloon inflations during angioplasty. Heart 87(1): 61-66
Cathelineau, G. 1997: Type Ii diabetes in 1997: genesis and perspectives. Diabetes and Metabolism 23(Suppl 4): 5
Buck, T.F. 1999: Type Ii diabetes in children. Tennessee Medicine: Journal of the Tennessee Medical Association 92(11): 418-419
Drzewoski, J.; Saryusz-Wolska, M.; Czupryniak, L. 2001: Type Ii diabetes mellitus and selected metabolic disorders in urban population aged over 35 years. Polskie Archiwum Medycyny Wewnetrznej 106(3): 787-791
Anonymous 1997: Type II diabetes mellitus clinical guidelines at primary health care level. A SEMDSA Consensus Document, 1997, in association with DESSA, ADSA. South African Medical Journal 87(4 Pt 3): 493-512
Gray, M.; Jones, I.R. 1997: Type Ii diabetes mellitus presenting as the Charles Bonnet syndrome. Journal of the Royal Society of Medicine 90(9): 503
Oberpichler-Schwenk, H. 1999: Type Ii diabetes mellitus. Rosiglitazone is effective against insulin resistance. Medizinische Monatsschrift für Pharmazeuten 22(9): 288-289
Libman, I.; Arslanian, S.A. 1999: Type Ii diabetes mellitus: no longer just adults. Pediatric Annals 28(9): 589-593
Frank, M. 1996: Type Ii diabetes mellitus: therapeutic concepts. Zeitschrift für Gastroenterologie 34(Suppl 2): 72-74
Cunningham, R. 1999: Perspectives. Safety-net providers surviving, but dependence on subsidies is ominous. Medicine and Health 53(44): Suppl: 1-4
Neel, J.V.; Weder, A.B.; Julius, S. 1998: Type Ii diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" hypothesis enters the 21st century. Perspectives in Biology and Medicine 42(1): 44-74
Miller, M. 1996: Type Ii diabetes: a treatment approach for the older patient. Geriatrics 51(8): 43
Scheen, A.J.; Paquot, N. 1999: Type Ii diabetes: diagnostic approaches, glycemia objectives and therapeutic strategies. Revue Medicale de Liege 54(8): 659-666
Drass, J.A.; Peterson, A. 1996: Type II diabetes: exploring treatment options. American Journal of Nursing 96(11): 45-49; Quiz 50
Bohannon, N.J.; Jack, D.B. 1996: Type Ii diabetes: tips for managing your older patients. Geriatrics 51(3): 28-35
Kolterman, O.G. 1993: Type Ii diabetes: who has the keys?. Journal of Laboratory and Clinical Medicine 121(4): 534-535
Rodby, R.A. 1997: Type Ii diabetic nephropathy: its clinical course and therapeutic implications. Seminars in Nephrology 17(2): 132-147
Weihmayr, T. 1997: Type II diabetic patients are predestined for therapy with natural healing methods. Natural healing series: diabetes mellitus. Fortschritte der Medizin 115(35-36): 30-32
Hasselkus, W.; Sailer, D.; Schärtel, B. 1996: Type II diabetic patients in general practice. A regional questionnaire survey--analysis and consequences. Fortschritte der Medizin 114(3): 15-17
Hinchliffe, R.J.; Singh-Ranger, R.; Whitaker, S.C.; Hopkinson, B.R. 2002: Type Ii endoleak: transperitoneal sacotomy and ligation of side branch endoleaks responsible for aneurysm sac expansion. Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists 9(4): 539-542
Almirall, J.; Amengual, M.J.; López, T.; Andreu, X.; Oristrell, J.; Sala, M.; Luelmo, J.; Dalmau, B. 2002: Type II essential mixed cryoglobulinemia and renal disease. Hepatitis C virus association. Nefrologia: publicacion oficial de la Sociedad Espanola Nefrologia 22(6): 531-539
Hayat, G.; de Mello, D.E.; Chung, H.D. 1996: Type Ii fiber predominance with motor neuron dysfunction. Electromyography and Clinical Neurophysiology 36(8): 451-455
Manta, P.; Kontoleon, P.; Panousopoulou, A.; Kalfakis, N.; Christomanou, H.; Papapetrou, P.; Papageorgiou, C. 1996: Type Ii glycogenosis and thyroxine binding globulin deficiency in the same family. Functional Neurology 11(2-3): 105-110
Arias, J.; Moral, A.; García, M.A.; Fernández-Rivas, M.; Abengózar, R.; Panadero, P.; Senent, C. 1994: Type II hereditary angioedema: presentation and follow-up of three cases. Allergologia et Immunopathologia 22(6): 244-249
Wetsel, R.A.; Kulics, J.; Lokki, M.L.; Kiepiela, P.; Akama, H.; Johnson, C.A.; Densen, P.; Colten, H.R. 1996: Type II human complement C2 deficiency. Allele-specific amino acid substitutions (Ser189 --> Phe; Gly444 --> Arg) cause impaired C2 secretion. Journal of Biological Chemistry 271(10): 5824-5831
Chambers, W.H.; Adamkiewicz, T.; Houchins, J.P. 1993: Type II integral membrane proteins with characteristics of C-type animal lectins expressed by natural killer (NK) cells. Glycobiology 3(1): 9-14
Amin, A.R. 2000: Type Ii interleukin-1beta receptor: a candidate for gene therapy in human arthritis. Clinical Orthopaedics and Related Research 2000(379(Suppl): S179-S188
Palomero-Domínguez, M.A.; Ramos-Fernández, J.M.; Domínguez-Santurino, F.; Ruiz-Gómez, M. 1998: Type II lissencephaly: presentation of intermediate form. Revista de Neurologia 27(158): 594-596
Post, E.D.; Wauters, E.A.; Huber, J.; Williams, E.D.; Lips, C.J. 1993: Type Ii multiple endocrine neoplasms (MEN IIB): an unusual cause of constipation. a plea for early thyroidectomy. Tijdschrift Voor Kindergeneeskunde 61(2): 63-68
Melkus, G.D. 1993: Type Ii non-insulin-dependent diabetes mellitus. Nursing Clinics of North America 28(1): 25-33
Windsor, R.S. 1997: Type Ii ostertagiasis in llamas. Veterinary Record 141(23): 608
Honda, T.; Ishida, K.; Hayama, M.; Kubo, K.; Katsuyama, T. 2000: Type Ii pneumocytes are preferentially located along thick elastic fibers forming the framework of human alveoli. Anatomical Record 258(1): 34-38
Tomioka, H. 2003: Type Ii pneumocytes in the evaluation of drug antimycobacterial activity. Expert Opinion on PharmacoTherapy 4(2): 127-139
Théau, D.; Maroteaux, P. 1993: Type II primordial microcephalic dwarfism. Report of a patient with completed growth. Annales de Pediatrie 40(5): 323-328
López-González, F.J.; Aldrey, J.M.; Rodríguez-Méndez, M.L.; Rivas, P.; de la Fuente, R.; Macías, M. 1999: Type Ii schizencephaly: magnetic resonance imaging. Revista de Neurologia 28(6): 641-642
Gamzu, R.; Zalel, Y.; Jacobson, J.M.; Screiber, L.; Achiron, R. 2002: Type Ii single umbilical artery (persistent vitelline artery) in an otherwise normal fetus. Prenatal Diagnosis 22(11): 1040-1043
Baron; Bethe; Brown; Cooperstein; Kahana 1987: Type Ii supernovae from prompt explosions. Physical Review Letters 59(6): 736-739
Baron; Cooperstein; Kahana 1985: Type Ii supernovae in 12Mcirdot and 15Mcirdot stars: the equation of state and general relativity. Physical Review Letters 55(1): 126-129
Staley, R.N.; Vance, J.P.; Loucks, C.D. 1998: Type Ii tooth cusp occurrence asymmetry in a human monozygotic twin pair. American Journal of Physical Anthropology 105(1): 93-95
Mouneimné, H.; Robert, J.; Jarlier, V.; Cambau, E. 1999: Type Ii topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa. Antimicrobial Agents and ChemoTherapy 43(1): 62-66
Krosnick, A. 1994: Type II, noninsulin dependent diabetes, IGT, and H-IRS. New Jersey Medicine 91(4): 235-238
Rabinowitz, I.; Randi, A.M.; Shindler, K.S.; Tuley, E.A.; Rustagi, P.K.; Sadler, J.E. 1993: Type IIB mutation His-505-->Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib. Journal of Biological Chemistry 268(27): 20497-20501
Iurassich, S.; Rocco, D.; Aurilia, A. 2001: Type IIi Ehlers-Danlos syndrome: correlations among clinical signs, ultrasound, and histologic findings in a study of 35 cases. International Journal of Dermatology 40(3): 175-178